Document:

Unit Purchase Agreement, dated as of July 3, 2006

 EXHIBIT 10.10 
 12% Senior Secured Note Due 2010 
 Warrants to Purchase Common Stock 
 VELOCITY EXPRESS CORPORATION 
 UNIT
PURCHASE AGREEMENT 
 This Purchase Agreement (this “Agreement”) is entered into on July 3, 2006 by and
among (i) Velocity Express Corporation, a Delaware corporation (the “Company”), (ii) New Delaware Delivery, Inc., Corporate Express Distribution Services, Inc., Velocity Express Administration, Inc., Velocity
Express Leasing, Inc., Velocity Express Management Business Trust, Velocity Express, Inc., VXP Leasing Mid-West, Inc., VXP Mid-West, Inc. (collectively, the “Guarantors”) and (iii) Exeter Capital Partners IV, L.P., a
Delaware limited partnership (“Purchaser”). 
 BACKGROUND: 
 A. Concurrently with the execution and delivery of this Agreement, the Company and Purchaser are entering into a Series A Preferred Stock, Common Stock
and Warrant Purchase Agreement (the “CD&L Securities Purchase Agreement”), pursuant to which the Company is acquiring from Purchaser certain shares of Series A Convertible Preferred Stock of CD&L, Inc., a Delaware
corporation (“CD&L”), shares of common stock of CD&L, and warrants to purchase shares of common stock of CD&L (collectively, the “CD&L Securities”) in exchange for the
Company’s issuance to Purchaser of the Units (as defined below) in accordance with the terms and conditions of this Agreement. 
 B. In
consideration for the acquisition of the CD&L Securities, the Company proposes to issue and sell to Purchaser, and Purchaser proposes to purchase from the Company, 3,205 units (the “Units”), consisting of $3,205,000.00
aggregate principal amount of the Company’s 12% Senior Secured Notes due 2010 (the “Notes”), as guaranteed by each of the Guarantors, and warrants (each, a “Warrant”) to purchase an aggregate of
1,105,725 shares (collectively, the “Warrant Shares”) of common stock, par value $0.004 of the Company (the “Common Stock”). Each Unit will consist of $1,000 principal amount of Notes and a Warrant to
purchase 345 Warrant Shares. The Units, the Notes, the Warrants and the Warrant Shares are hereinafter referred to collectively as the “Securities.” 
 C. The Notes are to be issued pursuant to the provisions of an indenture dated as of the date hereof (the “Indenture”) between
the Company and Wells Fargo Bank, N.A., as trustee (the “Trustee”). 
 D. The subsidiaries of the Company will
guarantee the Notes on a senior secured basis (the “Guarantees”). The Notes will have the benefit of the Security Documents (as defined in the Indenture), pursuant to which the Company and the Guarantors will, among other
things, grant liens on certain of their assets as set forth in the Security Documents. As used in this Agreement, “Notes” shall include the Guarantees, unless the context otherwise requires. 

 E. Concurrently with the execution and delivery of this Agreement, the Company is: (a) entering into
a Series Q convertible preferred stock purchase agreement with certain parties, pursuant to which the Company is selling and issuing shares of the Company’s Series Q convertible preferred stock, par value $0.004 per share (the
“Series Q Preferred Stock”), for aggregate cash consideration of at least $40.0 million; and (b) entering into Senior Secured Note and Warrant Purchase Agreements with certain other parties, pursuant to which the Company
is selling and issuing an additional 75,000 Units (the “Additional Units”) for aggregate cash consideration of at least $75.0 million. 
 F. Holders (including subsequent transferees) of the Warrants will have the registration rights set forth in the Registration Rights Agreement dated as of the date hereof (the “Registration Rights
Agreement”) among the Company, Purchaser and the purchasers of the Series Q Preferred Stock and the Additional Units. Pursuant to the Registration Rights Agreement, the Company has agreed to file with the Securities and Exchange
Commission (the “Commission”) a shelf registration statement (the “Shelf Registration Statement”) pursuant to Rule 415 under the Securities Act of 1933, as amended (the “Securities
Act”), to cover public resales of the Warrant Shares by the holders thereof and of the Common Stock issuable upon conversion of the Additional Units and Series Q Preferred Stock by the holders thereof. 
 G. The Securities will be offered and sold to Purchaser without being registered under the Securities Act in reliance on one or more exemptions
therefrom. 
 H. For purposes of this Agreement, each of this Agreement, the Indenture, the Securities, the Registration Rights Agreement,
the Escrow Agreement and the Security Documents referred to in the Indenture are referred to collectively as the “Transaction Documents”. 
 AGREEMENT: 
 NOW, THEREFORE, in consideration of the
mutual covenants hereinafter contained and for other good and valuable consideration, the receipt and sufficiency of which by each of the parties hereto is hereby acknowledged, it is agreed as follows: 
 1. Purchase and Sale of the Units. 
 (a) On the basis of the representations, warranties and agreements contained in this Agreement, and subject to the terms and conditions set forth in this Agreement, the Company agrees to issue and sell to Purchaser, and Purchaser agrees to
purchase from the Company, the Units in consideration for the acquisition of the CD&L Securities in accordance with the terms and conditions of the CD&L Securities Purchase Agreement. 
  

 2 

 (b) Concurrently with the execution and delivery of this Agreement, the Company shall deliver or cause to
be delivered to Purchaser certificates for the Notes and the Warrants in the name of Purchaser. Purchaser’s Notes will be in global or registered form, in accordance with written instructions previously provided by Purchaser. Concurrently with
the execution and delivery of this Agreement, Purchaser shall deliver or cause to be delivered to the Company the CD&L Securities in accordance with the terms and conditions of the CD&L Securities Purchase Agreement. 
 2. Representations and Warranties of the Company. The Company and the Guarantors, jointly and severally, represent and warrant to Purchaser
as follows: 
 (a) SEC Filings. The Company is subject to, and in full compliance with, the reporting requirements of Section 13
or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has made available to Purchaser through the EDGAR system true and complete copies of the Company’s Annual Report on Form 10-K
for the fiscal year ended July 2, 2005 (and any amendments thereto filed prior to the date of this Agreement), the Company’s Quarterly Reports on Form 10-Q for the fiscal periods ended October 1, 2005, December 31, 2005 and
April 1, 2006, each of the Company’s Current Reports on Form 8-K filed since July 2, 2005, the Company’s proxy statement pertaining to its annual meeting of stockholders to be held on June 28, 2006 and each other filing made
by the Company with the Commission under the Exchange Act since July 2, 2005 (collectively, the “SEC Filings”). The Company has not made any filings with the Commission under the Exchange Act since July 2, 2005
except for the SEC Filings. The SEC Filings, when they were filed with the Commission (or, if any amendment with respect to any such document was filed, when such amendment was filed), complied in all material respects with the applicable
requirements of the Exchange Act and the rules and regulations thereunder and did not, as of such date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. All reports and statements required to be filed by the Company under the Securities Act and the Exchange Act have been filed, together with all exhibits
required to be filed therewith. The Company and each of its direct and indirect subsidiaries (collectively, the “Subsidiaries”) are engaged in all material respects only in the business described in the SEC Filings, and the
SEC Filings contain a complete and accurate description in all material respects of the business of the Company and the Subsidiaries. Each registration statement and any amendment thereto filed by the Company and which has become effective since
January 1, 2004 pursuant to the Securities Act and the rules and regulations thereunder, as of the date such statement or amendment became effective, complied as to form in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein not misleading; and each prospectus filed pursuant to Rule 424(b) under the Securities
Act, as of its issue date and as of the closing of any sale of securities pursuant thereto did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading, and the Company will continue to make such filings as is necessary to comply with the obligations of a company with a class of shares registered
pursuant to Rule 12(g) of the Exchange Act. Each filing required to be made by the Company pursuant to the Securities Act or the Exchange Act in connection with the 

  

 3 

 
acquisition of CD&L Inc. or the acquisition of any interest in CD&L Inc. shall, when filed with the Commission, comply in all material respects with
the applicable requirements of the Securities Act and the Exchange Act and the rules and regulations thereunder and will not, as of such date, contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein not misleading. For purposes of clarity, when any of the following representations and warranties of the Company and the Guarantors in this Section 2 are qualified by reference to
disclosures in the SEC Filings, such qualification shall apply only to express statements set forth in the body of the relevant SEC Filings and will not include disclosures set forth in exhibits included in the SEC Filings. 
 (b) Organization, Good Standing. The Company and each of the Subsidiaries has been duly organized and is validly existing as a corporation in good
standing under the laws of the jurisdiction of its incorporation, except to the extent such concept is inapplicable in such jurisdiction. Each of the Company and the Subsidiaries is duly qualified and licensed and in good standing as a foreign
corporation in each jurisdiction in which its ownership or leasing of any properties or the character of its operations require such qualification or licensing (each of which jurisdictions is designated on Annex III to this Agreement), except where
the failure to be so qualified or licensed would not have a material adverse effect on the condition, financial or otherwise, results of operations, business or prospects of the Company and the Subsidiaries, taken as a whole (a “Material
Adverse Effect”) or where such concept is inapplicable in such jurisdiction. 
 (c) Subsidiaries. The Company does not
own or control, directly or indirectly, any corporation, association or other entity other than the Subsidiaries. There are no Subsidiaries other than those set forth on Exhibit 21.1 to the Annual Report on Form 10-K included among the SEC Filings
and CD&L Acquisition Corp. None of the Subsidiaries owns or controls directly or indirectly, any corporation, association or other entity. Except as described in the Annual Report on Form 10-K included among the SEC Filings, the Company owns,
either directly or through other Subsidiaries, all of the outstanding capital stock of each Subsidiary, in each case free and clear of all liens, charges, claims, encumbrances, pledges, security interests, defects or other restrictions or equities
of any kind whatsoever; and all outstanding capital stock of the Subsidiaries has been duly authorized and validly issued and is fully paid and non-assessable and not issued in violation of any preemptive rights or applicable securities laws.

 (d) Power and Authority. Each of the Company and the Subsidiaries has all requisite power and authority (corporate and other), and
has obtained any and all requisite authorizations, approvals, orders, licenses, certificates, franchises and permits of and from all governmental or regulatory officials and bodies, to own or lease its properties and conduct its business as
described in the SEC Filings, except where the failure to have any such power, authority, authorization, approval, order license, certificate, franchise or permit would not have a Material Adverse Effect; each of the Company and the Subsidiaries is
and has been doing business in compliance with all such authorizations, approvals, orders, licenses, certificates, franchises and permits and all federal, foreign, state and local laws, rules and regulations, except where the failure to be in
compliance would not have a Material Adverse Effect; and neither the Company nor any of the Subsidiaries has received any notice of proceedings relating to the revocation or modification of any such authorization, approval, order, license,
certificate, franchise or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect. 
  

 4 

 (e) Capitalization. The Company has an authorized capitalization as set forth in Annex IV
to this Agreement. All issued and outstanding equity securities of the Company (deeming the Series Q Preferred Stock and the Exchange Shares as outstanding for this purpose) have been duly authorized and validly issued and are fully paid and
non-assessable, as applicable; the holders thereof have no rights of rescission with respect thereto and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive
rights of any securityholder of the Company or any of the Subsidiaries or similar contractual rights granted by the Company or any of the Subsidiaries. 
 (f) The Securities. 
 (i) The Notes will be issued pursuant to the terms and
conditions of the Indenture. The Indenture conforms in all material respects to the requirements of the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), and the rules and regulations adopted by the
Commission under the Securities Act, the Exchange Act and the Trust Indenture Act (collectively, the “Rules and Regulations”) applicable to an indenture which is qualified thereunder. The Notes have been duly authorized and,
when validly authenticated, issued, delivered and paid for in the manner contemplated by the Indenture, will be duly authorized, validly issued and outstanding obligations of the Company, enforceable against the Company in accordance with their
terms and entitled to the benefits of the Indenture and the Security Documents. 
 (ii) The Warrants have been duly authorized
and when validly issued, delivered and paid for in the manner contemplated by this Agreement, will be duly authorized, validly issued and outstanding obligations of the Company, enforceable against the Company in accordance with their terms and will
be duly authorized, validly issued, fully-paid and non-assessable. The Warrant Shares issuable upon exercise of the Warrants will, upon payment and issuance in accordance with the terms of the Warrants, be duly authorized, validly issued, fully-paid
and non-assessable, and the Company has duly authorized and reserved the Warrant Shares for issuance upon exercise of the Warrants. 
 (iii) The Warrant Shares will be issued in compliance with all applicable federal and state securities laws and all applicable rules of the Nasdaq Stock Market or any other stock exchange on which the Common Stock is then listed.

 (iv) The Securities are not and will not be subject to any preemptive or other similar rights of any securityholder of the
Company or any of the Subsidiaries; all corporate action required to be taken on behalf of the Company for the authorization, issue and sale of the Securities has been duly and validly taken; and the certificates representing the Warrant Shares will
comply with the requirements of the Delaware General Corporation Law. 
  

 5 

 (v) Upon the issuance and delivery pursuant to the terms of this Agreement and the
Indenture, as applicable, of the Securities, the Purchaser will acquire good and marketable title thereto (subject to restrictions imposed by applicable federal and state securities laws) free and clear of any lien, charge, claim, encumbrance,
pledge, security interest, defect or other restriction or equity of any kind whatsoever (other than restrictions created by the Purchaser). 
 (g) Financial Statements. The consolidated financial statements of the Company and the Subsidiaries together with the related notes thereto included in the Annual Report on Form 10-K and the most recent Quarterly Report on Form 10-Q
included among the SEC Filings fairly present the financial position, income, changes in stockholders’ equity, cash flow and results of operations of the Company and the Subsidiaries at the respective dates and for the respective periods to
which they apply, and such financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”) and the Rules and Regulations, consistently applied throughout the periods involved
(except as may be disclosed therein or in the notes thereto, and, in the case of quarterly financial statements, as permitted by Form 10-Q under the Securities Act). Except as set forth in the financial statements of the Company set forth in the
Annual Report on Form 10-K and the most recent Quarterly Report on Form 10-Q included among the SEC Filings, since the date of the latest financial statements included in the most recent Quarterly Report on Form 10-Q included among the SEC Filings:
(i) neither the Company nor any of its Subsidiaries has incurred any liabilities, contingent or otherwise, except those incurred in the ordinary course of business, consistent (as to amount and nature) with past practices, none of which,
individually or in the aggregate, have had or could reasonably be expected to have a Material Adverse Effect; (ii) there has been no material adverse change or development involving a prospective material change in the condition, financial or
otherwise, or in the earnings, business, prospects or results of operations of the Company and the Subsidiaries, taken as a whole, whether or not arising in the ordinary course of business; (iii) neither the Company nor any Subsidiary has
entered into any material transaction other than in the ordinary course of business; and (iv) the Company has not declared or paid any dividend or made any other distribution on or in respect of its capital stock. The outstanding debt, the
property, both tangible and intangible, and the businesses of each of the Company and the Subsidiaries conform in all material respects to the descriptions thereof contained in the Annual Report on Form 10-K and the most recent Quarterly Report on
Form 10-Q included among the SEC Filings. 
 (h) Taxes. Each of the Company and the Subsidiaries has filed all income and franchise
tax returns required to be filed (after giving effect to all permissible extensions) through the date hereof by it in any jurisdiction, and has paid all taxes shown to be due on such returns or claimed to be due from such entities, other than those
being contested in good faith, except where the failure to so file or pay would not have a Material Adverse Effect. All tax liabilities, including those being contested by the Company or the Subsidiaries are adequately reserved for in the
Company’s financial statements (in accordance with GAAP). No tax deficiency has been asserted and no tax proceedings are pending or, to the knowledge of the Company, are threatened against the Company or any of the Subsidiaries which, if
adversely determined would have a Material Adverse Effect, and to the knowledge of the Company, no such deficiency or proceeding is contemplated. 
  

 6 

 (i) No Transfer Tax. No transfer tax, stamp duty or other similar tax is payable by or on behalf
of the Purchaser in connection with (i) the issuance by the Company of the Securities, (ii) the purchase by the Purchaser of the Notes or the Warrants from the Company or (iii) the consummation by the Company of any of its obligations
under this Agreement, the Indenture, the Warrants, the Escrow Agreement or the Security Documents. 
 (j) Insurance. Each of the
Company and the Subsidiaries maintains liability, casualty and other insurance (subject to customary deductions and retentions) against such risk of the types and in the amounts customarily maintained by companies of comparable size to the Company
engaged in similar businesses in similar industries, all of which insurance is in full force and effect. 
 (k) Litigation. There is
no action, suit, proceeding, litigation or governmental proceeding pending or, to the knowledge of the Company, threatened or contemplated against (or circumstances that are reasonably likely to give rise to the same), or involving the properties or
businesses of, the Company or any of the Subsidiaries which questions the validity of the capital stock of the Company or any of the Subsidiaries or any of the Transaction Documents or of any action taken or to be taken by the Company or any of the
Subsidiaries pursuant to or in connection with any of the Transaction Documents. There are no pending actions, suits or proceedings against or affecting the Company, its Subsidiaries or any of its or their properties involving an amount in
controversy in excess of $150,000; and to the knowledge of the Company, no such actions, suits or proceedings are threatened or contemplated. 
 (l) Authority and Binding Effect of Transaction Documents. 
 (i) The Company has the legal right and
corporate power and authority to authorize, issue, deliver and sell the Securities, to enter into the Transaction Documents and to consummate the transactions provided for in the Transaction Documents. This Agreement and each of the other
Transaction Documents has been duly and properly authorized, executed and delivered by the Company. When the Company has duly executed and delivered each of the other Transaction Documents (assuming the due execution and delivery thereof by each
other party thereto), each of the Transaction Documents will constitute a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except as rights to indemnification may be limited by federal
or state securities laws and except for the effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting the rights of creditors generally. 
 (ii) Each Guarantor has the legal right and corporate (or other) power and authority to authorize and make the Guarantees, to enter into
the Transaction Documents to which it will be a party and to consummate the transactions to which it will be a party provided for in such Transaction Documents. Each Guarantor has duly and properly authorized, executed and delivered this Agreement
and each of the other Transaction Documents to which it is a party. When each Guarantor has duly executed and delivered this Agreement and each of the other Transaction Documents to which it will be a party (assuming the due execution and delivery
thereof by each other party thereto), this Agreement and each of the other Transaction Documents to which such 

  

 7 

 
Guarantor will be a party will constitute a legal, valid and binding agreement of such Guarantor, enforceable against such Guarantor in accordance with its
terms, except as rights to indemnification may be limited by federal or state securities laws and except for the effect of bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting the rights of creditors
generally. 
 (iii) Prior to the date of this Agreement, the holders of a majority of the issued and outstanding shares of
Common Stock have executed and delivered to the Company, in accordance with the Delaware General Corporation Law, a duly executed and dated written consent of stockholders approving the issuance of the Securities, the entering into of the
Transaction Documents and the transactions contemplated thereby. 
 (m) Non-Contravention. 
 (i) None of the Company’s issue and sale of the Securities, the execution or delivery of the Transaction Documents, its performance
hereunder and thereunder or its consummation of the transactions contemplated herein and therein conflicts or will conflict with or results or will result in any breach or violation of any of the terms or provisions of, or constitutes or will
constitute a default under, or results or will result in a right of acceleration of performance or the creation or imposition of any lien, charge, claim, encumbrance, pledge, security interest, defect or other restriction or equity of any kind
whatsoever upon any property or assets of the Company or any of the Subsidiaries pursuant to the terms of, (A) the certificate of incorporation or by-laws of the Company or any of the Subsidiaries, (B) any license, contract, indenture,
mortgage, deed of trust, voting trust agreement, stockholders’ agreement, note, loan or credit agreement or other agreement or instrument to which the Company or any of the Subsidiaries is a party or by which it or any Subsidiary is or may be
bound or to which its or any of the Subsidiaries’ properties or assets is or may be subject, or any indebtedness, or (C) any statute, judgment, decree, order, rule or regulation directly applicable to the Company or any of the Subsidiaries
of any arbitrator, court, regulatory body or administrative agency or other governmental agency or body, having jurisdiction over the Company or any of the Subsidiaries or any of their respective activities or properties, which, with respect to the
foregoing clauses (B) and (C) only, breach, violation or default would have a Material Adverse Effect. 
 (ii) None
of the Guarantors’ grant of the Guarantees, the execution or delivery of the Transaction Documents to which any of them is a party, the performance by them of any of the Transaction Documents or their consummation of the transactions
contemplated in any of the Transaction Documents conflicts or will conflict with or results or will result in any breach or violation of any of the terms or provisions of, or constitutes or will constitute a default under, or results or will result
in a right of acceleration of performance or the creation or imposition of any lien, charge, claim, encumbrance, pledge, security interest, defect or other restriction or equity of any kind whatsoever upon any property or assets of the Company or
any of the Subsidiaries pursuant to the terms of, (A) the certificate of incorporation or by-laws of the Company or any of the Subsidiaries, (B) any license, contract, indenture, mortgage, deed of trust, voting trust agreement,
stockholders’ agreement, note, loan or credit 

  

 8 

 
agreement or other agreement or instrument to which the Company or any of the Subsidiaries is a party or by which it or any Subsidiary is or may be bound or
to which its or any of the Subsidiaries’ properties or assets is or may be subject, or any indebtedness, or (C) any statute, judgment, decree, order, rule or regulation directly applicable to the Company or any of the Subsidiaries of any
arbitrator, court, regulatory body or administrative agency or other governmental agency or body, having jurisdiction over the Company or any of the Subsidiaries or any of their respective activities or properties, which, with respect to the
foregoing clauses (B) and (C) only, breach, violation or default would have a Material Adverse Effect. 
 (iii)
Neither the Company nor any of the Subsidiaries (A) is in violation of its certificate of incorporation or by-laws, (B) is in default in the performance of any obligation, agreement or condition contained in any license, contract,
indenture, mortgage, installment sale agreement, lease, deed of trust, voting trust agreement, stockholders’ agreement, note, loan or credit agreement, purchase order, agreement or instrument evidencing an obligation for borrowed money or other
material agreement or instrument to which the Company or any of the Subsidiaries is a party or by which the Company or any of the Subsidiaries may be bound or to which the property or assets of the Company or any of the Subsidiaries is subject or
affected or (C) is in violation in any respect of any law, ordinance, governmental rule, regulation or court decree to which it or its property or assets may be subject, except any violation or default under the foregoing clauses (B) or
(C) as would not have a Material Adverse Effect. 
 (iv) Except as disclosed on Annex VII to this Agreement, none of:
(A) the execution, delivery or performance of the CD&L Securities Purchase Agreements or the Voting Agreements, (B) the consummation of the transactions contemplated therein or (C) the execution and delivery of the Merger
Agreement conflicts or will conflict with or results or will result in any breach or violation of any of the terms or provisions of, or constitutes or will constitute a default under, or results or will result in a right of acceleration of
performance or the creation or imposition of any lien, charge, claim, encumbrance, pledge, security interest, defect or other restriction or equity of any kind whatsoever upon any property or assets of CD&L Inc. pursuant to the terms of any
indenture, mortgage, deed of trust, note, loan or credit agreement or other agreement or instrument pertaining to indebtedness of CD&L or any of its subsidiaries to which CD&L Inc. or any of its subsidiaries is a party or by which CD&L
Inc. or any of its subsidiaries is or may be bound or to which CD&L Inc. or any of its subsidiaries’ properties or assets is or may be subject. 
 (n) Required Consents. Except as disclosed on Annex VIII to this Agreement, no consent, approval, authorization or order of, and no filing with, any court, arbitrator, regulatory body, government agency
or other body, domestic or foreign, or any other third party is required for the execution, delivery or performance of this Agreement, any of the other Transaction Documents or the transactions contemplated by this Agreement or any of the other
Transaction Documents, other than the filing of a Form D with the Commission under the Securities Act, the filing of an Information Statement with the Commission pursuant to Regulation 14C under the Exchange Act, the filing of an 

  

 9 

 
application to list the Notes on the Private Offerings, Resale and Trading through Automated Linkages Market (“Portal”), the filing
of an application to list the Warrant Shares on the Nasdaq Stock Market or as may be required under state securities or Blue Sky laws. 
 (o)
Matters. 
 (i) The Company and the Subsidiaries are in compliance in all material respects with all applicable
federal, state, local and foreign laws and regulations respecting employment and employment practices, terms and conditions of employment and wages and hours. To the knowledge of the Company, there are no pending investigations involving the Company
or any of the Subsidiaries by the U.S. Department of Labor or any other governmental agency responsible for the enforcement of such federal, state, local or foreign laws and regulations. To the knowledge of the Company, there is no unfair labor
practice charge or complaint against the Company or any of the Subsidiaries pending before the National Labor Relations Board or any strike, picketing, boycott, dispute, slowdown or stoppage pending or threatened against or involving the Company or
any of the Subsidiaries. Neither the Company nor any of the Subsidiaries is or ever have been a party to any collective bargaining agreement, and no collective bargaining agreement is currently being negotiated by the Company or any of the
Subsidiaries. No material labor dispute with the employees of the Company or any of the Subsidiaries exists or, to the knowledge of the Company, is imminent. 
 (ii) Neither the Company nor any of the Subsidiaries is a party to, or bound by, any employment or other contract or agreement that
contains any severance, termination pay or change of control liability or obligation, including, without limitation, any “excess parachute payment,” as defined in Section 280G(b) of the Internal Revenue Code. 
 (iii) Neither the Company nor any Subsidiary has any liability for the improper classification by the Company of such employees as
independent contractors or leased employees. 
 (p) ERISA. No “employee pension benefit plan,” “employee welfare
benefit plan” or “multi-employer plan” of the Company (“ERISA Plans”) as such terms are defined in Sections 3(2), 3(1) and 3(37), respectively, of the Employee Retirement Income Security Act of 1974, as amended
(“ERISA”), or any trust created thereunder has engaged in a “prohibited transaction” within the meaning of Section 406 of ERISA or Section 4975 of the Internal Revenue Code of 1986, as amended (the
“Code”) which could subject the Company to any material tax penalty on prohibited transactions and which has not adequately been corrected. No “accumulated funding deficiency” (as defined in Section 302 of
ERISA) or any of the events set forth in Section 4043(b) of ERISA (other than events with respect to which the 30-day notice under Section 4043 of ERISA has been waived) has occurred with respect to any employee benefit plan which might
reasonably be expected to have a Material Adverse Effect. 
  

 10 

 (q) Stabilization. None of the Company, any of the Subsidiaries or any Affiliate (as defined
below) of the Company or any Subsidiary has taken or will take, directly or indirectly, any action designed to or which has constituted or which might be expected to cause or result in, under the Exchange Act or otherwise, stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, the Series Q Preferred Stock, the Exchange Shares or otherwise. For purposes of this Agreement, an “Affiliate”
is any person or entity who, directly or indirectly, controls, is controlled by or is under common control with subject person or entity, where the term ‘control’ has the meaning ascribed to it under the Exchange Act. 
 (r) Intellectual Property. 
 (i) All trademarks, trade names and other rights to inventions, know-how, patents, copyrights, confidential information and other intellectual property, (collectively, the “Intellectual Property”) of the Company and
its Subsidiaries is currently in compliance with all legal requirements (including timely filings, proofs and payments of fees) and is valid and enforceable, except where the failure to be in compliance or to be valid and enforceable has not and
could not reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole and except as described on Annex VIII to this Agreement. No Intellectual Property of the Company or its Subsidiaries which is
necessary for the conduct of Company’s and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted has been or is now involved in any cancellation, dispute or litigation, and, to the
knowledge of the Company, no such action is threatened. No patent of the Company or its Subsidiaries has been or is now involved in any interference, reissue, re-examination or opposition proceeding. Except as set forth on Annex VIII to this
Agreement, the Company has no reason to believe, and has not received any written notice, that the conduct by the Company and the Subsidiaries of their respective businesses infringe or conflict with any such rights of others with respect to any of
the foregoing. 
 (ii) All of the licenses and sublicenses and consent, royalty or other agreements concerning Intellectual
Property which are necessary for the conduct of the Company’s and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted to which the Company or any Subsidiary is a party or by which
any of their assets are bound (other than generally commercially available, non-custom, off-the-shelf software application programs having a retail acquisition price of less than $10,000 per license) (collectively, “License
Agreements”) are valid and binding obligations of the Company or its Subsidiaries that are parties thereto and, to the knowledge of the Company, the other parties thereto, enforceable in accordance with their terms, except to the extent
that enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws affecting the enforcement of creditors’ rights generally, and there exists no event or condition which
will result in a material violation or breach of or constitute (with or without due notice or lapse of time or both) a default by the Company or any of its Subsidiaries under any such License Agreement. 
  

 11 

 (iii) The Company and its Subsidiaries own or have the valid right to use all of the
Intellectual Property that is necessary for the conduct of the Company’s and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted and for the ownership, maintenance and operation
of the Company’s and its Subsidiaries’ properties and assets, free and clear of all liens, encumbrances, adverse claims or obligations to license all such owned Intellectual Property and Confidential Information, other than licenses
entered into in the ordinary course of the Company’s and its Subsidiaries’ businesses. The Company and its Subsidiaries have a valid and enforceable right to use all third party Intellectual Property and Confidential Information used or
held for use in the respective businesses of the Company and its Subsidiaries. 
 (s) Real and Personal Property. The Company and each
Subsidiary has good and marketable title to all real properties and all other properties and assets owned by it, in each case free from liens, encumbrances and defects except those disclosed in the SEC Filings and except for liens, encumbrances and
defects that arise in the ordinary course of business and which are not material in amount and do not materially adversely affect the use made or proposed to be made of such property; and except as disclosed in the SEC Filings, the Company and each
Subsidiary holds any leased real or personal property under valid and enforceable leases with no exceptions that would materially interfere with the use made or currently planned to be made thereof by them 
 (t) Qualification of the Securities. 
 (i) The Notes satisfy the eligibility requirements of Rule 144A(d)(3) under the Securities Act. Application has been made to designate the Notes as Portal- eligible securities in accordance with the rules and
regulations of the NASD. The Company has been advised by the NASD that the Notes have been designated Portal-eligible securities in accordance with the rules and regulations of the NASD. 
 (ii) The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and is listed on the Nasdaq Stock Market under the
symbol “VEXP”. The Warrant Shares have been approved for listing on the Nasdaq Stock Market. The Company has taken no action that was designed to terminate, or that is likely to have the affect of terminating, trading of the Common Stock
on the Nasdaq Stock Market, nor has the Company received any notification that the Commission or the Nasdaq Stock Market is contemplating terminating such trading. The Company is, and after giving effect to the issuance of the Notes, the Warrants,
the Exchange Shares and the Series Q Preferred Stock and the entering into of the Transaction Documents will be, in compliance with applicable Nasdaq continued listing requirements following the Company’s filing and distribution of the Required
Information Statement (as defined below). There are no proceedings pending or, to the knowledge of the Company, threatened against the Company relating to the continued listing of the Common Stock on Nasdaq and the Company has not received any
notice of, nor to the knowledge of the Company is there any basis for, the delisting of the Common Stock from Nasdaq. 
  

 12 

 (u) Questionable Payments. Neither the Company nor any of the Subsidiaries has, nor, to the
knowledge of the Company, has any officer, director or employee of the Company or any of the Subsidiaries or any other person acting on behalf of the Company or any of the Subsidiaries, for the benefit of the Company or any such Subsidiaries at any
time during the last five years, (i) made any unlawful gift or contribution to any candidate for federal, state, local or foreign political office, or failed to disclose fully any such gift or contribution in violation of law, or (ii) made
any payment to any federal, state, local or foreign governmental officer or official, which would be reasonably likely to subject the Company or any of the Subsidiaries to any damage or penalty in any civil, criminal or governmental litigation or
proceeding (domestic or foreign). Each of the Company’s and the Subsidiaries’ internal accounting controls are sufficient to cause the Company and the Subsidiaries to comply in all material respects with the Foreign Corrupt Practices Act
of 1977, as amended. 
 (v) Security Interests. The Security Documents, upon execution and delivery thereof, will create, in favor of
the Trustee for the benefit of the Trustee and the holders of the Notes, a valid and enforceable, and upon filing of financing statements of the Collateral (as such term is defined in the Indenture) with the appropriate governmental authorities
(including payment of the appropriate filing or recording fees and any applicable taxes) and delivery of the applicable documents to the Trustee in accordance with the provisions of the Security Documents, perfected security interests in the
Collateral. Except as expressly contemplated by the Security Documents, the security interests in the Collateral will be senior to all other security interests in any existing or after acquired collateral of the Company and its Subsidiaries.

 (w) Minute Books Complete. The minute books of each of the Company and the Subsidiaries have been made available to Kelley
Drye & Warren LLP and summarize in all material respects all meetings and actions of the directors and stockholders of each of the Company and the Subsidiaries since the time of their respective incorporation. 
 (x) Environmental Matters. Neither the Company nor any of the Subsidiaries has been notified in writing that it is liable with respect to
obligations under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, or any similar law (“Environmental Laws”), except for any liability as would not have a Material Adverse Effect,
and it is not aware of any facts or circumstances which could reasonably be expected to result in any such liability. The Company and the Subsidiaries are in substantial compliance with all applicable existing Environmental Laws, except for such
instances of non-compliance which would not have a Material Adverse Effect. The term “Hazardous Material” means (i) any “hazardous substance” as defined by the Comprehensive Environmental Response, Compensation
and Liability Act of 1980, as amended, (ii) any “hazardous waste” as defined by the Resource Conservation and Recovery Act, as amended, (iii) any petroleum or petroleum product, (iv) any polychlorinated biphenyl and
(v) any pollutant or contaminant or hazardous, dangerous or toxic chemical, material, waste or substance regulation under or within the meaning of any other Environmental Law. To the Company’s knowledge, no disposal, release or discharge
of Hazardous Material has occurred on, in, at or about any of the facilities or properties of the Company or any of the Subsidiaries, except for any such disposal, release or discharge which is in compliance with Environmental Laws or which would
not have a Material Adverse Effect. Except as described in the SEC Filings, to the Company’s knowledge: (A) there has been no storage, disposal, generation, transportation, handling or treatment of hazardous substances or 

  

 13 

 
solid wastes by the Company or any of the Subsidiaries (or to the knowledge of the Company, any of its predecessors in interest) at, upon or from any of the
property now or previously owned or leased by the Company or any of the Subsidiaries in violation of any applicable law, ordinance, rule, regulation, order, judgment, decree or permit or which would require remedial action which has not been taken,
under any applicable law, ordinance, rule, regulation, order, judgment, decree or permit, except for such violations and failures to take remedial action which would not result in, singularly or in the aggregate, a Material Adverse Effect; and
(B) there has been no material spill, discharge, leak, emission, injection, escape, dumping or release of any kind onto such property or into the environment surrounding such property by the Company or any of the Subsidiaries of any solid waste
or Hazardous Materials, except for such spills, discharges, leaks, emissions, injections, escapes, dumping or releases which would not result in, singularly or in the aggregate, a Material Adverse Effect. 
 (y) Not Investment Company. The Company is not an “investment company” or a company controlled by an “investment company” or,
to the Company’s knowledge, an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended.

 (z) Private Offering. 
 (i) Neither the Company nor any Affiliate of the Company has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any “security” (as defined
in the Securities Act), which is or will be integrated with the sale of the Units in a manner that would require the registration of any of the Securities under the Securities Act. 
 (ii) None of the Company, any Affiliate of the Company or any other person acting on its or their behalf has engaged in any form of
general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act in connection with any offer or sale of the Securities. 
 (iii) None of the Company, any Affiliate of the Company or any other person acting on its or their behalf has engaged in any directed
selling efforts with respect to the Securities, and each of the Company and its Affiliates have complied with the offering restrictions requirement of Regulation S under the Securities Act. Terms used in this paragraph have the meanings given to
them by Regulation S under the Securities Act. 
 (iv) Assuming (A) the accuracy of the representations, warranties and
agreements of the Purchaser contained in Section 3 of this Agreement and (B) compliance by the Purchaser with the offering and transfer procedures and restrictions described in the Indenture and the Warrants, and after giving effect to the
offer and sale of the Series Q Preferred Stock and the Additional Units occurring concurrently with the offer and sale of the Securities contemplated by this Agreement, it is not necessary, in connection with the issuance and sale of the Units in
the manner contemplated by this Agreement to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act. 
  

 14 

 (aa) Payment Restrictions. No Subsidiary is prohibited, directly or indirectly, from paying any
dividends to the Company, from making any other distribution on such Subsidiary’s capital stock, from repaying to the Company any loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary’s property
or assets to the Company or any other Subsidiary. 
 (bb) Transactions with Affiliates. Except as disclosed in the SEC Filings and
except for the Expense Reimbursement Agreement with TH Lee Putnam Ventures, none of the officers, directors or 5% or greater stockholders of the Company, none of their respective Affiliates and, to the knowledge of the Company, none of the employees
of the Company is presently a party to any transaction with the Company or any Subsidiary (other than as holders of stock options and/or warrants, and for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner. 
 (cc) Internal Controls. Except as described in the SEC Filings, the Company is in material compliance with the provisions of the Sarbanes-Oxley Act of 2002 currently applicable to the Company. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as
necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and
(iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the SEC Filings, the Company has established
disclosure controls and procedures (as defined in Securities Act Rules 13a-13 and 15d-13) for the Company and designed such disclosure controls and procedures to ensure that material information relating to the Company, including the Subsidiaries,
is made known to the certifying officers by others within those entities, particularly during the period in which the Company’s most recently filed period report under the Securities Act, as the case may be, is being prepared. The
Company’s certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of the end of the period covered by the most recently filed Quarterly Report on Form 10-Q included among the SEC Filings and the
Company presented in its most recently filed periodic report under the Securities Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.
The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with GAAP and the applicable requirements of the Securities Act. 
 (dd) Credit Compliance. To the knowledge of the Company, neither the Company nor any agent acting on its behalf has taken or will take any action
that might cause this Agreement or the sale of the Notes to violate Regulation T, U or X of the Board of Governors of the Federal Reserve System, in each case as in effect on the date hereof. 
  

 15 

 (ee) Transaction Structure. The solicitation of the holders of the capital stock and debt
securities of CD&L Inc. to be acquired by the Company with the proceeds from the sale of the Units, the acquisition of the CD&L Securities, the related issue and sale of the Exchange Shares, the concurrent issue and sale of Series Q
Preferred Stock and the consummation of the sale of Units each have been and will be made in compliance with the reporting, disclosure and procedural requirements of the Securities Act, the Exchange Act, Delaware General Corporation Law, the Nasdaq
Stock Market and all other applicable laws, rules and regulations. The solicitation, delivery and performance of the Voting Agreements has been and will be made in compliance with the reporting, disclosure and procedural requirements of the
Securities Act, the Exchange Act, Delaware General Corporation Law, the Nasdaq Stock Market and all other applicable laws. 
 (ff)
Representations in Other Transaction Documents. To the knowledge of the Company, each representation and warranty set forth in the Transaction Documents of each party to the Transaction Documents, other than the Purchaser, which is not
qualified by a materiality standard is true and correct in all material respects, and each such representation and warranty that is qualified by a materiality standard is true and correct in all respects. 
 3. Representations and Warranties of Purchaser. By executing and delivering this Agreement, Purchaser represents to the Company as follows:

 (a) Purchaser Knowledge and Status. 
 (i) Purchaser is an “accredited investor” as defined in Regulation D under the Securities Act and has requested, received, reviewed and considered all information it deemed relevant in making an informed
decision to purchase the Securities, and has such business and financial experience as is required to give it the capacity to utilize the information received, to evaluate the risks involved in purchasing the Securities, and to protect its own
interests in connection with the purchase of the Securities and is able to bear the risks of an investment in the Securities; 
 (ii) Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act and Purchaser is acquiring the Units in the ordinary course of Purchaser’s business and for its
own account for investment only, has no present intention of distributing any of such Securities and has no arrangement or understanding with any other persons regarding the distribution of such Securities; 
 (iii) Purchaser will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy,
purchase or otherwise acquire or take a pledge of) any of the Securities except in compliance with the Securities Act, applicable state securities laws and the respective rules and regulations promulgated thereunder; 
 (iv) Purchaser has, in connection with its decision to purchase the Units, relied only upon the representations and warranties of the
Company 

  

 16 

 
contained in this Agreement. Purchaser understands that the Securities to be issued to Purchaser have not been registered under the Securities Act, or
registered or qualified under any state securities law in reliance on specific exemptions therefrom, which exemptions may depend upon, among other things, the bona fide nature of Purchaser’s investment intent as expressed in this Agreement, and
Purchaser is able to bear the economic risk of holding the Securities for an indefinite period of time and can afford a complete loss of its investment; and 
 (v) In connection with the private placement of the Units, no person has been authorized to provide any representation which is
inconsistent or in addition to those in the SEC Filings. Purchaser acknowledges that it has not received or relied on any such representations. 
 (b) International Actions. Purchaser acknowledges and agrees that no action has been or will be taken in any jurisdiction outside the United States by the Company that would permit an offering of the Securities, or possession or
distribution of offering materials in connection with the issue of the Securities, in any jurisdiction outside the United States. If Purchaser is located outside the United States, it has or will take all actions necessary for the sale of the
Securities to comply with all applicable laws and regulations in each foreign jurisdiction in which it offers, sells or delivers Securities or has in its possession or distributes any offering material, in all cases at its own expense. 

(c) Registration Required. Purchaser hereby covenants with the Company not to make any sale of the Securities without complying with the
provisions of this Agreement, the Indenture and the Warrants and, with respect to the Warrant Shares, the Registration Rights Agreement, and without effectively causing the prospectus delivery requirement under the Securities Act to be satisfied
(unless Purchaser is selling such Shares in a transaction not subject to the prospectus delivery requirement), and Purchaser acknowledges that the certificates evidencing the Securities will be imprinted with a legend that prohibits their transfer
except in accordance therewith. 
 (d) Power and Authority. 
 (i) Purchaser is duly organized and in good standing in the jurisdiction of its organization; 
 (ii) Purchaser has the full right, power, authority and capacity to enter into this Agreement and to consummate the transactions
contemplated hereby and Purchaser has taken all necessary action to authorize the execution, delivery and performance of this Agreement; and 
 (iii) this Agreement has been duly authorized, executed and delivered, and constitutes a valid and binding obligation of Purchaser enforceable against Purchaser in accordance with its terms, except as enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and except as 

  

 17 

 
enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law)
and except as the indemnification agreements of Purchaser in this Agreement may be legally unenforceable. 
 (e) Prohibited
Transactions. During the thirty (30) day period preceding the date of this Agreement, neither Purchaser nor any Affiliate of Purchaser, which (i) had knowledge of the transactions contemplated hereby, (ii) has or shares discretion
relating to Purchaser’s investments or trading or information concerning Purchaser’s investments, including in respect of the Securities, or (iii) is subject to Purchaser’s review concerning such Affiliate’s investments or
trading (collectively, “Trading Affiliates”), has, directly or indirectly, effected or agreed to effect any short sale, whether or not against the box, established any “put equivalent position” (as defined in Rule
16a-1(h) under the 1934 Act) with respect to the Common Stock, granted any other right (including, without limitation, any put or call option) with respect to the Common Stock or with respect to any security that includes, relates to or derived any
significant part of its value from the Common Stock or otherwise sought to hedge its position in the Common Stock, in each case for (A) the account for which Warrants have been acquired or (B) any other account in which the beneficial
owners of the account for which Warrants have been acquired are the beneficial owners of at least fifty percent (50%) of such account (each, a “Prohibited Transaction”). Prior to the earliest to occur of (A) the
effective date for the registration of the Warrant Shares or (B) 180 days after the date of this Agreement, Purchaser shall not engage, and shall not permit any Affiliate controlled by it to engage, directly or indirectly, in a Prohibited
Transaction. 
 (f) No Tax or Legal Advice. Purchaser understands that nothing in this Agreement, or any other materials presented to
Purchaser in connection with the purchase and sale of the Securities constitutes legal, tax or investment advice. Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in
connection with its purchase of the Securities. 
 4. Covenants and Agreements of the Company. The Company covenants and agrees
with Purchaser as follows: 
 (a) During the five-year period following the Closing Date, provided any of the Notes remain outstanding, the
Company shall furnish to Purchaser all reports, documents, information and financial statements filed by the Company with the Commission pursuant to the Trust Indenture Act, the Exchange Act or the Rules and Regulations. 
 (b) During the two-year period following the date of this Agreement, for so long as and at any time that the Company is not subject to Section 13 or
15(d) of the Exchange Act, upon request of any holder of the Notes, the Company shall furnish to such holder, and to any prospective purchaser or purchasers of the Notes designated by such holder, information satisfying the requirements of
subsection (d)(4) of Rule 144(A) under the Securities Act. This covenant is intended to be for the benefit of the holders from time to time of the Notes, and prospective purchasers of the Notes designated by such holders. 
  

 18 

 (c) The Company shall not, and it shall use reasonable efforts to ensure that no Affiliate of the Company
will, “offer,” “sell” or solicit offers to buy or otherwise negotiate in respect of any “security” (as each of such terms are defined in the Securities Act) which could be integrated with the sale of the Notes or the
Warrants in a manner that would require the registration of the Notes or the Warrants under the Securities Act. 
 (d) The Company shall not,
so long as the Notes are outstanding, be or become (and use its best efforts not to be or become owned by) an open-end investment company, unit investment trust or face-amount certificate company that is or is required to be registered under
Section 8 of the Investment Company Act, and the Company shall not be or become (and use its best efforts not to be or become owned by) a closed-end investment company required to be registered, but not registered under the Investment Company
Act. 
 (e) The Company shall comply with the all agreements set forth in the representation letters of the Company to The Depository Trust
Company relating to the approval of the Notes for “book-entry” transfers. 
 (f) For a period ending on the earlier of five
(5) years from the date of this Agreement or the date on which the aggregate principal amount of the Note (together with notes issued in connection with the sale of Additional Units simultaneous herewith) outstanding is less than $1,000,000,
the Company shall maintain the Portal (or, alternatively national securities exchange listing) listing of the Notes, and the Nasdaq Stock Market (or another national securities exchange) listing of the Common Stock. 
 (g) The Company agrees to file a Notice of Sale of Securities pursuant to Regulation D, Section 4(6), and/or Uniform Limited Offering Exemption on
Form D with respect to the Securities as required under Regulation D and to provide a copy thereof to Purchaser promptly after such filing. 
 (h) For a period of ninety (90) trading days (being a day on which the Nasdaq Stock Market is open for trading equity securities) after the effectiveness of the Shelf Registration Statement (the “Lock Up
Period”), the Company will not, directly or indirectly, (A) announce an offering of, or file a registration statement with the Commission relating to, any equity securities of the Company (other than the offering and registration
contemplated by the Registration Rights Agreement) or, without the prior written consent of the holders of a majority of the principal amount of Notes then outstanding, offer for sale, sell, assign, transfer, pledge, contract to sell or otherwise
dispose of (or enter into any transaction or device which is designed to, or could be expected to, result in the disposition or purchase by any person at any time in the future of) any shares of Common Stock or debt securities (other than short term
debt securities) or securities convertible into or exercisable or exchangeable for shares of Common Stock or debt securities (other than short term debt securities), or sell or grant options, warrants or rights with respect to any shares of Common
Stock or debt securities (other than short term debt securities) or securities convertible into or exercisable or exchangeable for Common Stock, debt securities (other than short term debt securities) or substantially similar securities (other than
the grant of options, warrants, convertible debenture or rights that are currently authorized pursuant to option plans existing on the date hereof), or (B) enter into any swap or other derivatives transaction that transfers to another, in whole
or in part, any of the economic benefits or risks of ownership of 

  

 19 

 
such shares of Common Stock, whether any such transaction described in the foregoing clauses (A) or (B) is to be settled by delivery of Common
Stock, debt securities (other than short term debt securities) or other securities, in cash or otherwise. Notwithstanding anything to the contrary contained herein, during the Lock Up Period (I) the Company may issue (x) the Securities as
contemplated by this Agreement, (y) shares of Common Stock (and rights to purchase such shares) under the Company’s employee benefit plans, qualified stock option plans or other employee compensation plans existing on the date hereof or
pursuant to currently outstanding options, warrants, convertible debentures or other rights to purchase or acquire Common Stock and (z) equity securities in one or more private placements by the Company, so long as the Company does not file a
registration statement with the Commission on behalf of the private placement investors until the Commission has declared effective the Shelf Registration Statement and (II) the Company may file one or more registration statements that include only
securities issuable under employee plans approved by the Board of Directors and registered on Form S-8. 
 (i) Disclosure of Transactions
and Other Material Information. The Company shall, on or before 9:00 a.m., New York City Time, on the first Business Day following the date of this Agreement, issue a press release (the “Press Release”) reasonably
acceptable to Context Capital, disclosing all material terms of the transactions contemplated by this Agreement, but not disclosing the identity of any of the Purchaser, and announcing the acquisition of the Company’s interest in CD&L Inc.
and the execution of the merger agreement with CD&L Inc. and, to the extent permitted by applicable law, disclosing the material terms of such acquisition and merger. On or before 9:00 a.m., New York City Time, on the second Business Day
following the date of this Agreement, the Company shall file a Current Report on Form 8-K describing the terms of the transactions contemplated by the Transaction Documents in the form required by the Exchange Act, and attaching the material
Transaction Documents (including, without limitation, this Agreement and all schedules and exhibits to this Agreement), as exhibits to such filing. From and after the issuance of the Press Release, no Purchaser shall be in possession of any
material, nonpublic information received from the Company, any of its Subsidiaries or any of its respective officers, directors, employees or agents, that is not disclosed in the Press Release. Except as expressly provided in the foregoing sentence,
the Company shall not, and shall cause each of its Subsidiaries and each of their respective officers, directors, employees and agents, not to, provide any Purchaser with any material, nonpublic information regarding the Company or any of its
Subsidiaries from and after the filing of the Press Release without the express written consent of such Purchaser. In the event of a breach of the foregoing covenant by the Company, any Subsidiary, or each of its respective officers, directors,
employees and agents, in addition to any other remedy available to the Purchaser, a Purchaser shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, nonpublic
information without the prior approval by the Company, its Subsidiaries, or any of its or their respective officers, directors, employees or agents; provided, that the Purchaser shall give to the Company notice at least twenty four (24) hours
prior to making any such disclosure and allow the Company the option of making such public disclosure during such twenty four (24) hour period. No Purchaser shall have any liability to the Company, its Subsidiaries, or any of its or their
respective officers, directors, employees, shareholders or agents for any such disclosure. 
  

 20 

 (j) In connection with the receipt of the written consent of the holders of at least 62.5 % of each
class of outstanding preferred stock of the Company (separately by class) and the holders of a majority of the issued and outstanding shares of Common Stock, which consent was obtained prior to the execution and delivery of this Agreement, approving
the issuance of Common Stock upon exercise of the Warrants and upon conversion of the Series Q Preferred Stock, the Company will prepare and file with the Commission an information statement pursuant to Rule 14c-2 of the Exchange Act regarding such
matters (the “Required Information Statement”) as soon as possible, and in any event within twenty (20) days (but if such twentieth (20th) day is not a Business Day, then on the next succeeding Business Day), after the date of this Agreement and thereafter mail such Required Information
Statement to its other stockholders as soon as practicable as such mailing is permitted in compliance with the Exchange Act. If the Commission reviews such information statement, the Company will seek to resolve all comments made by the Commission
so that the Information Statement can be mailed as expeditiously as possible. 
 5. Closing Deliveries. 
 (a) Concurrently with the execution and delivery of this Agreement, the Company shall deliver to Purchaser a copy of each Transaction Document, executed
by each party thereto other than Purchaser. 
 (b) Concurrently with the execution and delivery of this Agreement, the Company shall deliver
to the Purchaser the legal opinion of Briggs and Morgan P.A., counsel to the Company, addressed to the Purchaser and dated concurrently with this Agreement, in substantially the form attached hereto as Annex V to this Agreement. 
 (c) Concurrently with the execution and delivery of this Agreement, the Company shall deliver to the Purchaser a certificate of the Company signed on
behalf of the Company by the principal executive officer and by the chief financial or chief accounting officer of the Company, in their capacities as such, dated the date of this Agreement, to the effect that each of such persons has carefully
examined this Agreement and each of the other Transaction Documents, and that: 
 (i) the representations and warranties of
the Company and the Guarantors in this Agreement and each of the other Transaction Documents are true and correct; 
 (ii) no
stop order suspending the qualification or exemption from qualification of the Securities shall have been issued and no proceedings for that purpose shall have been commenced or, to the knowledge of the Company, be contemplated; 
 (iii) since the date of the most recent financial statements included in the SEC Filings, there has been no material adverse change in the
condition, financial or otherwise, business, prospects or results of operation of the Company and the Subsidiaries, taken as a whole; 
  

 21 

 (iv) none of the SEC Filings or any amendment or supplement thereto includes any untrue
statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; and 
 (v) subsequent to the respective dates as of which information is given in the SEC Filings: (A) neither the Company nor any of the
Subsidiaries has incurred up to and including the date of this Agreement, other than in the ordinary course of its business, any material liabilities or obligations, direct or contingent; (B) neither the Company nor any of the Subsidiaries has
paid or declared any dividends or other distributions on its capital stock; (C) neither the Company nor any of the Subsidiaries has entered into any material transactions not in the ordinary course of business; (D) there has not been any
change in the capital stock (other than pursuant to the Company’s stock option plan or stock purchase plan or the exercise of warrants outstanding on such respective dates) or the short-term or long-term debt of the Company or any of the
Subsidiaries; (E) neither the Company nor any of the Subsidiaries has sustained any material loss or damage to its property or assets, whether or not insured; and (F) there is no litigation which is pending or, to the Company’s
knowledge, threatened or contemplated against the Company or any of its Affiliates which would, if decided adversely, have a Material Adverse Effect. 
 (d) Concurrently with the execution and delivery of this Agreement, the Company shall have delivered to Purchaser a certificate signed on behalf of the Company by the secretary of the Company, in his capacity as such,
dated the date of this Agreement, as to: 
 (i) the absence of any contemplated proceeding for the merger, consolidation,
liquidation or dissolution of the Company or any Subsidiary, as the case may be, or the sale of all or substantially all of its assets; 
 (ii) the due adoption and full force and effect of the By-laws of the Company (with a copy of the By-laws attached); 
 (iii) resolutions adopted by the Board of Directors of the Company and/or a committee thereof authorizing the Securities and the consummation of the transactions contemplated by this Agreement and each of the other
Transaction Documents (with copies of such resolutions attached); and 
 (iv) the incumbency, authorization and signatures of
those officers of the Company signing this Agreement, each of the other Transaction Documents and/or any certificate delivered in connection therewith. 
 6. Payment of Expenses. Each party hereto shall pay its own expenses incurred in connection with the negotiation, execution, delivery and performance of this Agreement, except as otherwise provided in
this Section 6. For clarity, the Company acknowledges (a) it will pay the fees payable to the NASD, CUSIP Service Bureau and DTC incurred in connection with the listing of the Notes for trading on Portal, and (b) it will pay the fees
and expenses required to be paid by it under the other Transaction Documents and any other related agreements entered into by it on the date hereof in connection with the transactions contemplated by this Agreement. 
  

 22 

 7. Representations and Agreements to Survive Delivery. All representations, warranties and
agreements contained in this Agreement or contained in certificates of officers of the Company submitted pursuant to this Agreement shall remain operative and in full force and effect regardless of any investigation made by or on behalf of
Purchaser, the Company, or of the Subsidiaries, and shall survive the issuance and delivery of the Units to Purchaser. 
 8. Reliance
by the Placement Agent. The parties agree and acknowledge that Jefferies & Company, Inc., as placement agent, may rely on the representations, warranties, agreements and covenants of the Company contained in this Agreement and may
rely on the representations and warranties of the Purchaser set forth in Sections 3(a), (b), (c) and (f) of this Agreement as if such representations, warranties, agreements and covenants, as applicable, were made directly to
Jefferies & Company, Inc. The parties further agree that Jefferies & Company, Inc. may rely on or, if Jefferies & Company, Inc. so requests, be specifically named as an addressee of, the legal opinions to be delivered
pursuant to Section 5(c) of this Agreement. 
 9. Allocation of Purchase Price to Notes and Warrants. The Company and
Purchaser agree that for U.S. federal income tax purposes: (a) the purchase price for each Unit ($943.40 and $3,023,597 in the aggregate) shall be allocated between the Note and the Warrants which comprise such Unit based on their relative fair
market values on the date of issuance of the Units; (b) the fair market value of the Warrants is equal to $1.094 per Warrant Share initially issuable upon exercise thereof ($1,209,663.15 in the aggregate for all of the Warrants) and the fair
market value of each $1,000 principal amount of Notes is $565.97; (c) the aggregate “issue price” of the Notes under section 1273(b) and (c) of the Code is $1,813,933.85 and (d) the “yield to maturity” of the Notes
under section 1272(a) of the Code is 24.37%. The Company and Purchaser agree to use such allocation of the purchase price between the Notes and the Warrants and the resulting issue price of the Notes for all relevant U.S. federal income tax
purposes. 
 10. Miscellaneous. 
 (a) Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be mailed (i) if within domestic United States by first-class registered or certified airmail, or
nationally recognized overnight express courier, postage prepaid, or by facsimile, or (ii) if delivered from outside the United States, by International Federal Express (or comparable service) or facsimile, and shall be deemed given (A) if
delivered by first-class registered or certified mail domestic, three business days after so mailed, (B) if delivered by nationally recognized overnight carrier, one (1) business day after so mailed, (C) if delivered by International
Federal Express (or comparable service), two (2) business days after so mailed, (D) if delivered by facsimile, upon electric confirmation of receipt on the first business day after the transaction and shall be delivered as addressed as
follows: 
 if to the Company or the Guarantors, to: 
 Velocity Express Corporation 
 One Morningside Drive North 
 Building B – Suite 300 
 Westport, CT 06880 
 Attention: Chief Financial Officer 
 Telephone: (612) 337-4525 
 Telecopy: (612) 337-4588 
  

 23 

 if to Purchaser, to: 
  

									
	Exeter Capital Partners IV, L.P.	 		 		 	
	10 East 53rd Street, 32nd Floor	 		 		 	
	New York, New York 10022	 		 		 	
	Attention:	 	  
	 		 		 	
	Telephone:	 	  
	 		 		 	
	Telecopy:	 	  
	 		 		 	

 or, in each case, or at such other address or addresses as may have been furnished in writing in accordance with
this Section 9(a) by the party to be so notified. 
 (b) Binding Effect. This Agreement shall inure solely to the benefit of and
shall be binding upon Purchaser, the Company, the Guarantors, and their respective successors, legal representatives and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in
respect of or by virtue of this Agreement or any provisions contained in this Agreement. 
 (c) Entire Agreement. This Agreement,
together with the other Transaction Documents, constitutes the entire agreement of the parties hereto and supersedes all prior written or oral agreements, understandings and negotiations with respect to the subject matter hereof. 
 (d) Headings. The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed
to be part of this Agreement. 
 (e) Severability. In case any provision contained in this Agreement should be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained in this Agreement shall not in any way be affected or impaired thereby. 
 (f) Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written instrument
signed by the Company and Purchaser. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any
other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to any Purchaser to
amend or consent to a waiver or modification of any provision of any Transaction Document unless the same consideration is also offered to all Purchasers who then hold Securities. 
  

 24 

 (g) Governing Law. THIS AGREEMENT SHALL BE CONSTRUED, PERFORMED AND ENFORCED IN ACCORDANCE WITH
THE LAWS OF THE STATE OF NEW YORK. 
 (h) Consent to Jurisdiction, etc. 
 (i) EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE EXCLUSIVE JURISDICTION
OF THE NEW YORK SUPREME COURT IN THE CITY AND STATE OF NEW YORK AND ANY APPELLATE COURT THEREFROM OR THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK AND ANY APPELLATE COURT THEREFROM (COLLECTIVELY, THE “NEW YORK
COURTS”), IN ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT RELATING THERETO, AND EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND
UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH PROCEEDING MAY BE HEARD AND DETERMINED IN THE NEW YORK COURTS. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN
OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. 
 (ii) EACH OF THE PARTIES HERETO HEREBY
IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT IT MAY LEGALLY AND EFFECTIVELY DO SO, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY IN ANY OF THE NEW YORK COURTS. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH PROCEEDING IN ANY OF THE
NEW YORK COURTS. 
 (iii) EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY CONSENTS TO SERVICE OF PROCESS IN
THE MANNER PROVIDED FOR NOTICES IN SECTION 10(a). NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY TO THIS AGREEMENT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 
  

 25 

 (i) Interpretation. The language used in this Agreement shall be deemed to be the language chosen
by the parties to express their mutual intent and no rule of strict construction shall be applied against any party. 
 (j) Counterparts
and Facsimiles. This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more
counterparts have been signed by each party hereto and delivered to the other parties. This Agreement may also be executed and delivered via facsimile, which shall be deemed an original. 
 [signature page follows] 
  

 26 

 IN WITNESS WHEREOF, the undersigned have executed this Purchase Agreement as of the date first
above written. 
  

					
	The Company:
		
		 	VELOCITY EXPRESS CORPORATION
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

	
	The Guarantors:
		
		 	CORPORATE EXPRESS DISTRIBUTION SERVICES, INC.
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

		
		 	VELOCITY EXPRESS LEASING, INC.
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

 [Signature Page to Unit Purchase Agreement] 
  

					
	The Guarantors (continued):
		
		 	VELOCITY EXPRESS, INC.
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

					
		 	VXP LEASING MID-WEST, INC.
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

		
		 	VXP MID-WEST, INC.
			
		 	By:	 	 /s/ Edward W. Stone

		 	Name:	 	 Edward W. Stone

		 	Title:	 	 Chief Financial Officer

	
	Purchaser:
		
		 	EXETER CAPITAL PARTNERS IV, L.P.
			
		 	BY:	 	EXETER IV ADVISORS, L.P. GENERAL PARTNER
			
		 	BY:	 	EXETER IV ADVISORS, INC., GENERAL PARTNER
			
		 	By:	 	 /s/ Kurt Bergquist

		 	Name:	 	Kurt Bergquist
		 	Title:	 	Vice President

 [Signature Page to Unit Purchase Agreement] 

 EXHIBIT 10.12 
 Annex I 
 Units Purchased 
  

			
	 Name of Purchaser
	 	 Number of Units

		 	

 EXHIBIT 10.12 
 Annex II 
 Guarantors 
 Corporate Express Distribution Services, Inc. 
 Velocity Express Leasing, Inc. 
 Velocity Express, Inc. 
 VXP Leasing Mid-West, Inc. 
 VXP Mid-West, Inc. 

 EXHIBIT 10.12 
 Annex III 
 Jurisdictions in which Qualified 

 EXHIBIT 10.12 
 Annex IV 
 Capitalization 

 Annex V 
 Form of Briggs & Morgan P.A. Opinion 

 Annex VI 
 Contraventions and Consents 
  

	A.	Contraventions: 

  

	B.	Consents: 

 Annex VII 
 IP Disclosures 
 On November 30, 2000, Velocity
Express, Inc. entered into a Settlement Agreement with Velocity Courier, Inc. in connection with the parties’ use of certain “Velocity” trademarks. Pursuant to the terms of the settlement, Velocity Express, Inc. is permitted to use
the Velocity trademarks anywhere in the United States except for the City of Chicago and the territory that extends 50 miles from the Chicago city limits, but within the State of Illinois. The Settlement Agreement required Velocity Express, Inc. to
amend its trademark applications to reflect this exclusion. The Company anticipates that it will initiate concurrent use proceedings in order to clarify territorial rights with respect to two “Velocity” trademark registrations
(Velocity and Velocity Express).Series A Preferred Stock, Common Stock and Warrant Purchase Agreement

 EXHIBIT 10.11 
 SERIES A PREFERRED STOCK, COMMON STOCK AND 
 WARRANT PURCHASE AGREEMENT

 (Share Consideration) 
 THIS SERIES A PREFERRED STOCK, COMMON STOCK AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 3rd day of July, 2006, by and between VELOCITY EXPRESS CORPORATION, a Delaware corporation
(the “Buyer”) and EXETER CAPITAL PARTNERS IV, L.P., a Delaware limited partnership (the “Seller”). 
 W I T N E S S E T H: 
 WHEREAS, Seller is the owner of 65,617 shares (the “Shares”) of Series
A Preferred Stock, of CD&L, Inc., a Delaware corporation (the “Company”) which may be converted into a total of 656,170 shares of Common Stock of the Company that it acquired immediately prior to the execution and delivery of
this Agreement from the United States Business Administration as court appointed receiver for Exeter Venture Lenders, L.P. (“Exeter Venture”); and 
 WHEREAS, Seller is also the owner of 328,084 additional shares (the “Common Shares”) of Common Stock of the Company that it acquired immediately prior to the execution and delivery of this
Agreement from Exeter Venture; and 
 WHEREAS, Seller currently holds a Warrant pursuant to a Warrant Agreement (as defined below)
(the “Warrant”) entitling Seller to purchase up to 84,375 shares of Common Stock of the Company that it acquired immediately prior to the execution and delivery of this Agreement from Exeter Venture; and 
 WHEREAS, Seller desires to sell and transfer to Buyer and Buyer desires to purchase and acquire from Seller, all of the Shares, Common Shares and
the Warrant, all upon the terms and conditions hereinafter set forth; and 
 WHEREAS, prior to the execution and delivery of this
Agreement, the Board of Directors of the Company has duly and validly taken all actions required to: (a) approve the execution and delivery of that certain Agreement and Plan of Merger of even date herewith, by and between the Company, Buyer
and CD&L Acquisition Corp., a Delaware corporation (the “Merger Agreement”); (b) prevent any right issued pursuant to that certain Stockholder Protection Rights Agreement, dated as of December 27, 1999 between the
Company and American Stock Transfer & Trust Company, as Rights Agent, and amended as of April 14, 2004 (the “Stockholder Protection Rights Agreement”) from being exercisable pursuant to the Stockholder Protection
Rights Agreement as a result of the transactions contemplated herein and under the Merger Agreement; (c) prevent any Separation Time (as such term is defined in the Stockholder Protection Rights Agreement) from occurring as a result of the
transactions contemplated herein or under the Merger Agreement; (d) waive any and all rights the Company 

 
may have under that certain Warrant Agreement dated as of January 29, 1999 by and among the Company, Seller, Paribas (as defined below) and Exeter
Venture which would restrict, prevent or inhibit the consummation of the transactions contemplated in this Agreement, including, without limitation, any right to request a legal opinion from Seller or Paribas with respect to the transactions
contemplated in this Agreement pursuant to Section 14(b) of the Warrant Agreement and any rights of first offer pursuant to Section 14(d) of the Warrant Agreement; (e) waive any and all rights the Company may have under that certain
Restructuring and Exchange Agreement dated as of April 14, 2004 by and among the Company, Seller, Paribas, Exeter Venture and the individuals listed therein as “Investors” (the “Restructuring Agreement”) which would
restrict, prevent or inhibit the consummation of the transactions contemplated under this Agreement, including, without limitation, any obligation of Seller or Paribas to provide an opinion of counsel under Section 5.9 of the Restructuring
Agreement in connection with the transactions contemplated in this Agreement and the obligation of any holder (“Holders”) of Series A Convertible Subordinated Debentures (the “Debentures”) to provide an opinion of
counsel under Section 6.9 of the Restructuring Agreement with respect to the transfer of the Debentures as contemplated in the Series A Convertible Subordinated Debenture Purchase Agreement by and between the Holders and Buyer; and
(f) waive any rights which the Company may own or posses to redeem the Shares under that certain Certificate of Designations, Preferences and Rights of Series A Convertible Redeemable Preferred Stock of CD&L, Inc. filed with the Secretary
of State of the State of Delaware on April 14, 2004 (the “Certificate of Designations”) until the later of: (i) the expiration of the First Purchaser Restricted Period (as defined in the Merger Agreement); and
(ii) ten (10) days after the expiration of the Second Purchaser Restricted Period (as defined in the Merger Agreement), if any; and (g) waive the applicability of Section 203 of the Delaware General Corporation Law with respect
to the Company and the transactions contemplated herein and under the Merger Agreement; and 
 WHEREAS, prior to the execution and
delivery of this Agreement, BNP Paribas (“Paribas”) or the “Investor”) has, conditioned upon the execution and delivery of the Merger Agreement: (a) duly and validly consented to the sale and transfer of the
Shares, Common Shares and the Warrant from Seller to Buyer, as contemplated by this Agreement; (b) waived any and all rights of co-sale which the Investor may have in connection with the transactions contemplated hereunder pursuant to that
certain Stockholders Agreement dated April 14, 2004 by and among the Company and certain stockholders of the Company (the “Stockholders Agreement”) including, without limitation, any rights of co-sale under Section 2.1 of
the Stockholders Agreement; and (c) waived any and all tag along rights which the Investor may have pursuant to the Warrant Agreement, including, without limitation, any tag along rights under Section 15 of the Warrant Agreement (the
foregoing collectively referred to as the “Consent and Waiver”); and 
 WHEREAS, prior to the execution and delivery
of this Agreement and conditioned upon the execution and delivery of the Merger Agreement, the Investor has, as a holder of Preferred Stock and pursuant to Section 5.2(b) of the Stockholders Agreement, consented to the Company entering into the
Merger Agreement; and 
 WHEREAS, prior to the execution and delivery of this Agreement and conditioned upon the execution and
delivery of the Merger Agreement, the Investor and other Stockholders (as 

  

 2 

 
such term is defined in the Stockholders Agreement) have waived any and all rights of first refusal the Investor or other Stockholder may have in connection
with the transactions contemplated hereunder pursuant to the Stockholders Agreement, including, without limitation, all rights of first refusal provided for under Section 3.1 of the Stockholders Agreement. 
 NOW, THEREFORE, in consideration of the mutual covenants hereinafter contained and for other good and valuable consideration, the receipt and
sufficiency of which by each of the parties hereto is hereby acknowledged, it is agreed as follows: 
 1. Purchase of Shares, Common
Shares and Warrant; Purchase Price. Subject to the terms and conditions hereinafter set forth, Seller agrees to assign, transfer and deliver to Buyer, and Buyer agrees to purchase and acquire from Seller, on the Closing Date, all of
Seller’s right, title and interest in and to all the Shares, Common Shares and the Warrant in exchange for 2,465,418 shares of Common Stock of Buyer (the “Buyer Shares”). In connection with Buyer’s purchase from Seller of
the Shares, Common Shares and Warrants in exchange for the Buyer Shares, Seller agrees to execute and deliver to Buyer the Terms and Conditions for Exchange of Shares annexed hereto as Exhibit “A” (the “Terms and
Conditions”). 
 2. Closing. 
 (a) Closing. The closing (the “Closing”) of the transactions contemplated under this Agreement shall take place upon execution and delivery of this Agreement and each document or instrument to
be delivered hereunder by each of the parties hereto and delivery by Buyer of certificates representing the Buyer Shares (the “Certificates”) and the simultaneous execution and delivery of the Merger Agreement and funding of the
Paying Agent with the Merger Consideration as required thereunder (the “Closing Date”). 
 (b) Seller Closing
Deliveries. At Closing, Seller shall deliver or cause Exeter Venture to deliver to Buyer the following: 
 (i) an executed original of
this Agreement; 
 (ii) the certificates representing the Shares, Common Shares and the Warrant (or to the extent that such certificates
representing the Shares, Common Shares and the Warrant have been lost or destroyed, an affidavit of lost stock certificate representing the Shares, Common Shares and the Warrant) together with a duly executed Stock and Warrant Power transferring
such Shares, Common Shares and Warrant in the form attached hereto as Exhibit “B” (the “Stock and Warrant Power”); 
 (iii) duly executed originals of the Terms and Conditions; 
 (iv) Duly executed original of the
Registration Rights Agreement attached hereto as Exhibit “C” (the “Registration Rights Agreement”); and 
 (v) a counterpart to the Consent and Waiver, duly executed by Seller. 
  

 3 

 (c) Buyer Closing Deliveries. At Closing, Buyer shall deliver: (i) to Seller, an executed
original of this Agreement duly executed originals of the Terms and Conditions, a duly executed original of the Registration Rights Agreement, and the Certificates; and (ii) to the Company, an executed Waiver. 
 3. Representations and Warranties of Seller. Seller hereby represents and warrants to Buyer as follows: 
 3.1 Authorization. Seller is duly organized, validly existing and in good standing under the laws of its state of organization. Seller has the full
right, power, legal capacity and authority to execute this Agreement and to perform all of the agreements, undertakings, covenants, representations and warranties herein contained. This Agreement has been duly executed and delivered by Seller and
constitutes Seller’s legal, binding and enforceable obligation, subject to bankruptcy, insolvency, reorganization and other laws affecting creditors rights generally, and subject to remedies, the enforcement of which vests in the discretion of
courts of equitable jurisdiction. Seller is not currently subject to any voluntary and to its knowledge any involuntary, bankruptcy or insolvency proceedings. 
 3.2 Title to Shares, Common Shares and Warrants. Seller is the sole owner of the Shares, Common Shares and Warrants. Subject to the consents and waivers being obtained as provided in the recitals to this
Agreement, (a) Seller has the unrestricted right to sell and transfer the Shares, Common Shares and Warrants to Buyer and to assign its rights pursuant to the Accompanying Agreements (as defined below) to Buyer, and (b) pursuant to the
terms hereof Seller will transfer and deliver to the Buyer the Shares, Common Shares and Warrants free and clear of all liens, encumbrances, options, or other adverse claims (as defined in Article 8 of the Uniform Commercial Code as in effect in the
State of New York) of any kind whatsoever. 
 3.3 No Violation. Subject to the consents and waivers that have been obtained as
provided in the recitals to this Agreement, the execution of this Agreement and the delivery of the Shares, Common Shares and the Warrant by Seller to Buyer and the performance by Seller of its respective obligations hereunder and the consummation
by Seller of the transactions contemplated by this Agreement will not: (a) contravene any provision of the Certificate of Incorporation of Seller; or (b) conflict with, result in any breach of, or constitute a default (or an event which
would, with the passage of time or the giving of notice or both, constitute a default) under, or give rise to a right to terminate, amend, modify, abandon or accelerate, the Warrant itself or any contract or agreement which is applicable to or
binding upon or enforceable against Seller. 
 3.4 Section 16 of the Exchange Act. If Seller is the beneficial owner of more than
10% of any class of equity security of the Company and is subject to the reporting and short-swing liability provisions of Section 16 of the Securities Exchange Act of 1934 (the “Exchange Act”), Seller hereby represents and
warrants to Buyer that: (i) other than the purchase of the Shares, Common Shares and Warrant from Exeter Venture, Seller has not acquired any securities of the Company within the six (6) month period ending on the date of this Agreement;
(ii) the consummation of the transactions set forth herein by Seller will not result in a nonexempt short-swing transaction under Section 16 of the Exchange Act with respect to Seller; and (iii) consummation of the transactions set
forth herein by Seller will not result in liability under Section 16(b) of the Exchange Act to Seller, Buyer or the Company. 
  

 4 

 3.5 Exclusivity of Representations. EXCEPT AS PROVIDED HEREIN, SELLER EXPRESSLY DISCLAIMS ANY AND
ALL EXPRESS OR IMPLIED WARRANTIES. 
 4. Representations and Warranties of Buyer. Buyer hereby represents and warrants to
Seller as follows: 
 4.1 Authorization. Buyer is duly organized, validly existing and in good standing under the laws of its state of
organization and was not organized for the specific purpose of acquiring the Shares, Common Shares or the Warrant. Buyer has the full right, power, legal capacity and authority to execute this Agreement and to perform all of the agreements,
undertakings, covenants, representations and warranties herein contained. The execution and delivery of this Agreement and the issuance of the Senior Secured Note and Buyer Warrant has been duly authorized by all necessary Buyer corporate action.
This Agreement has been duly executed and delivered by Buyer and constitutes Buyer’s legal, binding and enforceable obligation, subject to bankruptcy, insolvency, reorganization and other laws affecting creditors rights generally, and subject
to remedies, the enforcement of which vests in the discretion of courts of equitable jurisdiction. 
 4.2 No Violation. Subject to the
consents and waivers that have been obtained as provided in the recitals to this Agreement, the execution of this Agreement and the delivery of the Senior Secured Note and Buyer Warrant by Buyer to Seller and the performance by Buyer of its
respective obligations hereunder and the consummation by Buyer of the transactions contemplated by this Agreement will not: (a) contravene any provision of the Certificate of Incorporation of Buyer; or (b) conflict with, result in any
breach of, or constitute a default (or an event which would, with the passage of time or the giving of notice or both, constitute a default) under, or give rise to a right to terminate, amend, modify, abandon or accelerate, the Senior Secured Note
or Buyer Warrant, any contract or agreement which is applicable to or binding upon or enforceable against Buyer. 
 4.3 Purchase Entirely
for Own Account. Buyer hereby represents and warrants that the Shares, Common Shares and the Warrant are being purchased for Buyer’s own account and for investment and without the intention of reselling or redistributing the same, that
Buyer has made no agreement with others regarding any of such Shares, Common Shares and the Warrant and that Buyer’s financial condition is such that it is not likely that it will be necessary to dispose of any of such Shares, Common Shares and
the Warrant in the foreseeable future. Buyer is aware that, in the view of the Securities and Exchange Commission, a purchase of the Shares, Common Shares and the Warrant with an intent to resell by reason of any foreseeable specific contingency or
anticipated change in market value, or any change in the condition of the Company or its business, or in connection with a contemplated liquidation or settlement of any loan obtained for the acquisition of the Shares, Common Shares or the Warrant
and for which the Shares, Common Shares and the Warrant were pledged as security, would represent an intent inconsistent with the representations set forth above. 
  

 5 

 4.4 Reliance Upon Seller’s Representations. Buyer understands that the Shares, Common Shares
and Warrants will not be registered under the Securities Act of 1933, as amended (the “1933 Act”), based on one or more exemptions therefrom, and that Buyer’s reliance on such exemption is predicated on Seller’s
representations set forth herein. Buyer realizes that the basis for the exemption may not be present if, notwithstanding such representations Buyer intends to acquire the Shares, Common Shares or the Warrant for a fixed or determinable period in the
future, or for a market rise, or for sale if the market does not rise. 
 4.5 Acknowledgement by Buyer. Buyer hereby acknowledges and
agrees that it has conducted its own independent investigation, verification, review and analysis of the business, operations, assets, liabilities, results of operations, financial condition, technology and prospects of the Seller and the Company,
which investigation, review and analysis was conducted by Buyer to the extent Buyer deemed appropriate, by its representatives. Buyer has had the opportunity to review the public filings with the Securities and Exchange Commission relating to Seller
and the Company and all documents delivered therewith (the “SEC Filings”). In entering into this Agreement, Buyer hereby acknowledges that it has relied solely upon the aforementioned investigation, review and analysis and not on
any factual representations or opinion of Seller or any persons affiliated with Seller, with respect to matters and operations of Seller and the Company and Buyer acknowledges and agrees, to the fullest extent permitted by law, that: 
 (a) Neither Seller nor any of its directors, officers, partners, members, employees, affiliates, controlling persons, agents, advisors or representatives
makes or has made any oral or written representation or warranty, either express or implied (except the specific representations and warranties of the Seller as set forth in this Agreement), as to the accuracy or completeness of any of the
information reviewed by Buyer; and 
 (b) Neither Seller nor any of its directors, officers, partners, members, employees, affiliates,
controlling persons, agents, advisors or representatives shall have any liability or responsibility whatsoever to Buyer or its directors, officers, partners, employees, affiliates, controlling persons, agents or representatives on any basis
(including in contract or tort, under United States securities laws or otherwise) based upon any information provided or made available, to Buyer or its directors, officers, employees, partners, members, affiliates, controlling persons, advisors,
agents or representatives (or any omissions therefrom), except that the foregoing limitations shall not apply to Seller insofar as the Seller has made specific representations and warranties set forth in this Agreement. 
 4.6 No Further Representations. Buyer acknowledges that neither Seller nor any of its directors, officers, partners, members, employees,
affiliates, controlling persons, agents, advisors or representatives make any representations as to the business, properties, financial condition or operating history of the Company or the success or viability of the business proposed to be
conducted by the Company after the Closing Date. 
  

 6 

 4.7 Investment Experience; Risks. Buyer is able to bear the economic risk of the investment in the
Shares, Common Shares and the Warrant. Buyer has knowledge and experience in financial and business matters, is capable of evaluating the merits and risks of the prospective investment in the Shares, Common Shares and Warrant and is able to bear
such risks. Buyer understands that an investment in the Shares, Common Shares and the Warrant is highly speculative but believes that the investment is suitable for Buyer based upon the investment objectives and financial needs of Buyer, and has
adequate means for providing for its current financial needs and personal contingencies and has no need for liquidity of investment with respect to the Shares, Common Shares and the Warrant. Buyer recognizes that the prospective investment in the
Shares, Common Shares and the Warrant involves a high degree of risk, including, but not limited to, the risks described in the SEC Filings. 
 4.8 Accredited Investor. Buyer is an “accredited investor” as defined in Rule 501(a) promulgated under the 1933 Act. 
 4.9 Restricted Securities. Buyer realizes that (i) the purchase of the Shares, Common Shares and the Warrant is a long-term investment; (ii) Buyer must bear the economic risk of investment in the Shares and the Warrant for
an indefinite period of time because the Shares and Warrant have not been registered under the 1933 Act and, therefore, cannot be sold unless they are subsequently registered under the 1933 Act, or an exemption from such registration is available;
and (iii) the transferability of the Shares and the Warrant is restricted. Buyer is aware that the Shares and the Warrant may not be sold pursuant to Rule 144 promulgated under the 1933 Act unless the conditions of that Rule are met.

 4.10 Exclusivity of Representations. EXCEPT AS PROVIDED HEREIN, BUYER EXPRESSLY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED
WARRANTIES. 
 5. Assignment of Rights Under Accompanying Agreements. By execution and delivery of this Agreement and
conditioned upon the consummation of the Prior Transactions, on the Closing Date, Seller shall grant, assign and transfer to Buyer Seller’s full right, title and interest in and to: (a) the Stockholders Agreement; (b) that certain
Registration Rights Agreement dated as of April 14, 2004 by and between the Company and the Investors and certain other investors referenced therein (the “Company Registration Rights Agreement”); and (c) the Warrant
Agreement (collectively, the “Accompanying Agreements”). Buyer hereby assumes all of the obligations of Seller pursuant to the Accompanying Agreements. 
 6. Delivery of Waiver. In addition to any other condition provided for herein, the Closing of this Agreement is expressly conditioned upon Buyer executing and delivering that certain Waiver (the
“Waiver”) to Company, in the form attached hereto as Exhibit “D”. 
 7. Miscellaneous.

 7.1 Notice. 
 (a) Any
notice or other communication required or permitted 

  

 7 

 
hereunder shall be in writing and shall be deemed to have been duly given on (i) the date of service if served personally; (ii) three
(3) business days after the date of mailing, if mailed by first class mail, registered or certified, postage prepaid, return receipt requested; or (iii) one (1) business day after delivery to the courier if sent by private courier
guaranteeing next day delivery, delivery charges prepaid. 
 (b) Notices shall be sent to the following addresses: (i) if to Buyer, to
One Morningside Drive North, Building B, Suite 300, Westport, Connecticut, 06880, Attention: General Counsel, or such other address as may hereafter be designated in writing by Buyer, with a copy to Budd Larner, P.C., 150 John F. Kennedy Parkway,
Short Hills, New Jersey 07078, Attn: James F. Fitzsimmons, Esq.; and (ii) if to Seller, to One Liberty Square, 12th Floor, Boston Massachusetts 02109, with a copy to Kirkpatrick & Lockhart Nicholson Graham LLP, 599 Lexington Avenue, New York, NY 10022, Attn: John W. Kaufmann, or such other address as may hereafter be designated in
writing by the applicable Seller. 
 7.2 Severability. The invalidity of any provision of this Agreement, or part thereof, shall not
affect the validity or enforceability of the remainder of such provision and/or this Agreement. 
 7.3. Benefit. All the terms and
provisions hereof shall inure to the benefit of and be binding upon the successors and assigns of the Buyer and the respective successors and assigns of Seller. 
 7.4. Counterparts; Facsimile Signatures. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, and all of which together shall be deemed to constitute one
and the same Agreement. A facsimile signature to this Agreement of any party shall be considered to have the same binding legal effect as an original signature 
 7.5. Headings. The headings of the paragraphs of this Agreement are for convenience and reference only and do not constitute a part of this Agreement and in no way modify, interpret or construe the
understanding of the parties hereto. 
 7.6. Governing Law; Jurisdiction. 
 (a) This Agreement and the rights and obligations of the parties hereunder shall be construed and enforced in accordance with the laws of the State of
Delaware, without giving effect to the principles to the conflicts of law thereof. 
 (b) Each party to this Agreement irrevocable consents
and agrees that any legal action or proceeding with respect to this Agreement and any action for enforcement of any judgment in respect thereof will be brought in the federal or state courts located within the jurisdiction of the United Stated
District Court for the Southern District of New York, and, by execution and delivery of this Agreement, each party to this Agreement irrevocably submits to and accepts for itself and in respect of its property, generally and unconditionally, the
exclusive jurisdiction of the aforesaid courts and appellate courts from any appeal thereof. Each party to 

  

 8 

 
this Agreement further irrevocably consents to the service of process out of any of the aforesaid courts in any such action or proceeding by the mailing of
copies thereof in the manner set forth in Section 7.1 hereof. Each party to this Agreement hereby irrevocably waives any objection which it may now have or hereafter have to the laying of venue of any of the aforesaid actions or proceedings
arising out of or in connection with this Agreement brought in any of the courts referred to above and hereby further irrevocably waives and agrees not to plead or claim in any such court that any such action or proceeding brought in any such court
is an inconvenient forum. Nothing in this Section shall be deemed to constitute a submission to jurisdiction, consent or waiver with respect to any matter not specifically referred to herein. 
 7.7. Entire Agreement. This Agreement constitutes the entire understanding between the parties hereto and may not be changed, nor modified orally,
but only by the amendment to the Agreement in writing, signed by the party against whom enforcement of any change or modification in sought. 
 7.8. Integration. This Agreement supersedes all prior agreements and understandings among the parties to this Agreement and contains the full understanding of the parties hereto with respect to the subject matter hereof; and there
are no representations, warranties, agreements or undertakings other than expressly contained herein or therein. 
 7.9
Interpretation. In all references herein to any parties, persons, entities or corporations, the use of any particular gender or the plural or singular number is intended to include the appropriate gender or number as the text of the within
instrument may require 
 7.10 Modification. This Agreement may be modified or amended only by a written instrument duly signed by all
of the parties hereto or their respective successors or assigns. 
 7.11 Assignments and Successors. No party may assign any of its
rights under this Agreement without the prior written consent of the other parties to this Agreement. Subject to the preceding sentence, this Agreement will apply to, be binding in all respects upon, and inure to the benefit of the successors and
permitted assigns of the parties. 
 7.12 Benefits Only to Parties. Nothing expressed by or mentioned in this Agreement is intended or
shall be construed to give any person other than the parties hereto and their respective successors and permitted assigns any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained, this
Agreement and all conditions and provisions hereof being intended to be and being for the sole and exclusive benefit of the parties hereto and their respective successors and permitted assigns; provided, however, to the extent that the Company has
any rights under the Warrants or Accompanying Agreements the Company shall be a third party beneficiary of this Agreement. 
 7.13 Further
Assurances. Each Seller and Buyer, at their own cost and expense, promptly shall execute such documents and other instruments and take such further actions as may be reasonably required or desirable to carry out the provisions hereof and to
consummate the transactions contemplated hereby. 
  

 9 

 7.14 Waiver of Trial by Jury. EACH OF THE PARTIES HERETO, TO THE EXTENT PERMITTED BY APPLICABLE
LAW, HEREBY IRREVOCABLY WAIVES ALL RIGHT OF TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ANY MATTER ARISING HEREUNDER. 
 7.15 Recitals. The recitals to this Agreement are incorporated herein by this reference and shall be construed as if they are a part of this
Agreement. 
 [SIGNATURE PAGE FOLLOWS] 
  

 10 

 IN WITNESS WHEREOF, Seller and Buyer have executed this Series A Preferred Stock, Common Stock and
Warrant Purchase Agreement as of the date first above written. 
  
  

			
	 BUYER:

	
	 Velocity Express Corporation,
 a Delaware corporation

		
	 By:
	 	 /s/ Edward W. Stone
  

	 Print Name: Edward W. Stone

	 Print Title: Chief Financial Officer

  

			
	SELLER:
	
	Exeter Capital Partners IV, L.P.
		
	 By:
	 	 Exeter IV Advisors, L.P.,
 General Partner

		
	 By:
	 	 Exeter IV Advisors, Inc.,
 General Partner

  

			
	 By:
	 	 /s/ Kurt Bergquist
  

	 Print Name: Kurt Bergquist

	 Print Title: Vice President

 [Signature Page to Series A Preferred Stock, Common Stock and Warrant Purchase Agreement
– Exeter Capital (Share Consideration)] 
  

 11 

 EXHIBIT A 
 TERMS AND CONDITIONS 
 TERMS AND CONDITIONS
FOR EXCHANGE OF SHARES 
 1. Agreement to Exchange the Shares; Closing
Date. 
 1.1 Purchase and Sale. At the Closing (as hereinafter defined), the Company will exchange with Exeter Capital Partners
IV, L.P. (“Exeter Capital”) 2,465,418 shares of Common Stock (the “Shares”) of the Company for the Velocity Shares and Warrant. 
 2. Deliveries at Closing; Closing Obligations. The purchase and sale of the Shares (the “Closing”) shall occur (the “Closing Date”) concurrent with or immediately following the execution and
delivery of Purchase Agreement to which these Terms and Conditions are attached. 
 2.1 Certain Closing Deliveries 
 (a) At the Closing, the Company shall deliver to Exeter Capital one or more stock certificates representing the Shares, each such certificate to be
registered in the name of Exeter Capital. 
 (b) At the Closing, the Company shall deliver to Exeter Capital an executed copy of the
Registration Rights Agreement. 
 3. Representations, Warranties of the Company. In addition to those terms defined above and
elsewhere in this Agreement, the following terms shall have the meanings set forth below: 
 “Affiliate”, as applied to any
Person, means any other Person directly or indirectly controlling, controlled by, or under common control with, that Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms
“controlling”, “controlled by” and “under common control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of
that Person, whether through the ownership of voting securities or by contract or otherwise. 
 “Company’s Knowledge”
means the actual knowledge of the executive officers (as defined in Rule 405 under the 1933 Act) of the Company, after due inquiry. 
 “Common Stock Equivalent” means any preferred stock, option, warrant, convertible bond, debt instrument or any other convertible instrument that can be converted into Common Stock. 
 “Intellectual Property” means all of the following: (i) patents, patent applications, patent disclosures and inventions (whether or
not patentable and whether or not reduced to practice); (ii) trademarks, service marks, trade dress, trade names, corporate names, logos, slogans and 

  

 12 

 
Internet domain names, together with all goodwill associated with each of the foregoing; (iii) copyrights and copyrightable works;
(iv) registrations, applications and renewals for any of the foregoing; and (v) proprietary computer software (including but not limited to data, data bases and documentation). 
 “Material Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of operations, condition
(financial or otherwise), business, or prospects of the Company and its Subsidiaries taken as a whole, or (ii) the ability of the Company to perform its obligations under the Transaction Documents. 
 “Nasdaq” means The Nasdaq Stock Market, Inc. 
 “Person” means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated
organization, governmental authority or any other form of entity not specifically listed herein. 
 “Subsidiary” of any
Person means another Person, an amount of the voting securities, other voting ownership or voting partnership interests of which is sufficient to elect at least a majority of its Board of Directors or other governing body (or, if there are no such
voting interests, 50% or more of the equity interests of which) is owned directly or indirectly by such first Person. 
 “Transaction
Documents” means this Agreement and the Registration Rights Agreement. 
 The Company hereby represents and warrants to Exeter Capital that, except
as set forth in the schedules delivered herewith (collectively, the “Disclosure Schedules”): 
 3.1 Organization, Good Standing
and Qualification. Each of the Company and its Subsidiaries is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to
carry on its business as now conducted and to own its properties. Each of the Company and its Subsidiaries is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the conduct of its business or
its ownership or leasing of property makes such qualification or leasing necessary unless the failure to so qualify has not and could not reasonably be expected to have a Material Adverse Effect. 
 3.2 Authorization. The Company has full power and authority and has taken all requisite action on the part of the Company, its officers, directors
and stockholders necessary for (i) the authorization, execution and delivery of this Agreement and the other Transaction Documents, (ii) the authorization of the performance of all obligations of the Company under this the Transaction
Documents, and (iii) the authorization, issuance and delivery of the Shares. The Transaction Documents constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject
to (i) bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally and (ii) laws relating to the availability of specific
performance, injunctive relief or other equitable remedies. 
 3.3 Capitalization. All of the issued and outstanding shares of the
Company’s and its subsidiaries capital stock have been duly authorized and validly issued and are fully paid, nonassessable and were issued in full compliance with applicable state and federal securities law 

  

 13 

 
and any rights of third parties; the holders thereof have no rights of rescission with respect thereto and are not subject to personal liability by reason of
being such holders; and none of such securities were issued in violation of the preemptive rights of any securityholder of the Company or any of the Subsidiaries or similar contractual rights granted by the Company or any of the Subsidiaries.

 3.4 Valid Issuance. The Shares are duly and validly authorized and, when issued and paid for, will be validly issued, fully paid
and nonassessable, free and clear of all encumbrances and restrictions, except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws. 
 3.5 Consents. The execution, delivery and performance by the Company of the Transaction Documents and the offer, issuance and sale of the Shares
require no consent of, action by or in respect of, or filing with, any Person, governmental body, agency, or official other than (i) filings that have been made pursuant to applicable state securities laws, (ii) post-sale filings pursuant
to applicable state and federal securities laws, which were not required to be made prior to Closing and (iii) such consents as have been previously obtained. 
 3.6 SEC Filings; Business. 
 (a) The Company is subject to, and in full compliance with, the
reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has made available to Exeter Capital through the EDGAR system true and complete copies of the
Company’s Annual Report on Form 10-K for the fiscal year ended July 2, 2005 (and any amendments thereto filed prior to the date of this Agreement), the Company’s Quarterly Reports on Form 10-Q for the fiscal periods ended
October 1, 2005, December 31, 2005 and April 1, 2006, each of the Company’s Current Reports on Form 8-K filed since July 2, 2005, and the Company’s proxy statement pertaining to its annual meeting of stockholders
to be held on June 28, 2006 and each other filing made by the Company with the Securities and Exchange Commission (the “Commission”) under the Exchange Act (collectively, the “SEC Filings”). The Company has not made any
filings with the Commission under the Exchange Act since July 2, 2005 except for the SEC Filings and documents that are only required to be furnished to the Commission. The SEC Filings, when they were filed with the Commission (or, if any
amendment with respect to any such document was filed, when such amendment was filed), complied in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder and did not, as of such date,
contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. All
reports and statements required to be filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”) and the Exchange Act have been filed, together with all exhibits required to be filed therewith. The Company and
each of its direct and indirect subsidiaries (collectively, the “Subsidiaries”) are engaged in all material respects only in the business described in the SEC Filings, and the SEC Filings contain a complete and accurate description in all
material respects of the business of the Company and the Subsidiaries. 
  

 14 

 (b) Each registration statement and any amendment thereto filed by the Company and which has become
effective since January 1, 2004 pursuant to the Securities Act and the rules and regulations thereunder, as of the date such statement or amendment became effective, complied as to form in all material respects with the Securities Act and did
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein not misleading; and each prospectus filed pursuant to Rule 424(b) under
the Securities Act, as of its issue date and as of the closing of any sale of securities pursuant thereto did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order
to make the statements made therein, in the light of the circumstances under which they were made, not misleading, and the Company will continue to make such filings as is necessary to comply with the obligations of a company with a class of shares
registered pursuant to Rule 12(g) of the Exchange Act. 
 3.7 Intentionally Omitted. 
 3.8 No Conflict, Breach, Violation or Default. The execution, delivery and performance of the Transaction Documents by the Company and the
issuance and sale of the Shares will not conflict with or result in a breach or violation of any of the terms and provisions of, or constitute a default under (i) the Company’s Certificate of Incorporation or the Company’s Bylaws,
both as in effect on the date hereof (true and complete copies of which have been made available to Exeter Capital through the EDGAR system), or (ii)(a) any statute, rule, regulation or order of any governmental agency or body or any court, domestic
or foreign, having jurisdiction over the Company, any Subsidiary or any of their respective assets or properties, or (b) any agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or a Subsidiary is
bound or to which any of their respective assets or properties is subject. 
 3.9 Title to Properties. Except as disclosed in the SEC
Filings and except for liens, encumbrances and defects that arise in the ordinary course of business and do not impair the Company’s ownership or use of such properties, the Company and each Subsidiary has good and marketable title to all real
properties and all other properties and assets owned by it, in each case free from liens, encumbrances and defects that would materially affect the value thereof or materially interfere with the use made or currently planned to be made thereof by
them; and except as disclosed in the SEC Filings, the Company and each Subsidiary holds any leased real or personal property under valid and enforceable leases with no exceptions that would materially interfere with the use made or currently planned
to be made thereof by them. 
 3.10 Certificates, Authorities and Permits. The Company and each Subsidiary possess adequate
certificates, authorities or permits issued by appropriate governmental agencies or bodies necessary to conduct the business now operated by it, and neither the Company nor any Subsidiary has received any notice of proceedings relating to the
revocation or modification of any such certificate, authority or permit that, if determined adversely to the Company or such Subsidiary, could reasonably be expected to have a Material Adverse Effect, individually or in the aggregate. 
  

 15 

 3.11 ERISA. No “employee pension benefit plan,” “employee welfare benefit
plan” or “multi-employer plan” of the Company (“ERISA Plans”) as such terms are defined in Sections 3(2), 3(1) and 3(37), respectively, of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
or any trust created thereunder has engaged in a “prohibited transaction” within the meaning of Section 406 of ERISA or Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”) which could subject the
Company to any material tax penalty on prohibited transactions and which has not adequately been corrected. No “accumulated funding deficiency” (as defined in Section 302 of ERISA) or any of the events set forth in
Section 4043(b) of ERISA (other than events with respect to which the 30-day notice under Section 4043 of ERISA has been waived) has occurred with respect to any employee benefit plan which might reasonably be expected to have a Material
Adverse Effect. 
 3.12 Labor Matters. 
 (a) The Company and the Subsidiaries are in compliance in all material respects with all applicable federal, state, local and foreign laws and regulations respecting employment and employment practices, terms and
conditions of employment and wages and hours. Except as set forth in Schedule 3.12 hereto, to the Company’s Knowledge, there are no pending investigations involving the Company or any of the Subsidiaries by the U.S. Department of Labor or any
other governmental agency responsible for the enforcement of such federal, state, local or foreign laws and regulations. To the Company’s Knowledge, there is no unfair labor practice charge or complaint against the Company or any of the
Subsidiaries pending before the National Labor Relations Board or any strike, picketing, boycott, dispute, slowdown or stoppage pending or threatened against or involving the Company or any of the Subsidiaries. Neither the Company nor any of the
Subsidiaries is or ever have been a party to any collective bargaining agreement, and no collective bargaining agreement is currently being negotiated by the Company or any of the Subsidiaries. No material labor dispute with the employees of the
Company or any of the Subsidiaries exists or, to the Company’s Knowledge, is imminent. 
 (b) Neither the Company nor any of the
Subsidiaries is a party to, or bound by, any employment or other contract or agreement that contains any severance, termination pay or change of control liability or obligation, including, without limitation, any “excess parachute
payment,” as defined in Section 280G(b) of the Internal Revenue Code. 
 (c) Neither the Company nor any Subsidiary has any
liability for the improper classification by the Company of their employees as independent contractors or leased employees. 
 3.13
Intellectual Property. 
 (a) Except as set forth in Schedule 3.13 hereto, all Intellectual Property of the Company and its
Subsidiaries is currently in compliance with all legal requirements (including timely filings, proofs and payments of fees) and is valid and enforceable, except where the failure to be in compliance or to be valid and enforceable has not and could
not reasonably be expected to have a Material Adverse Effect on the Company and its Subsidiaries taken as a whole. Except as set forth in Schedule 3.13 hereto, no Intellectual Property of the Company or its Subsidiaries which is necessary for
the conduct of Company’s 

  

 16 

 
and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted has been or is now involved in any
cancellation, dispute or litigation, and, to the Company’s Knowledge, no such action is threatened. No patent of the Company or its Subsidiaries has been or is now involved in any interference, reissue, re-examination or opposition proceeding.

 (b) All of the licenses and sublicenses and consent, royalty or other agreements concerning Intellectual Property which are necessary for
the conduct of the Company’s and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted to which the Company or any Subsidiary is a party or by which any of their assets are bound
(other than generally commercially available, non-custom, off-the-shelf software application programs having a retail acquisition price of less than $10,000 per license) (collectively, “License Agreements”) are valid and binding
obligations of the Company or its Subsidiaries that are parties thereto and, to the Company’s Knowledge, the other parties thereto, enforceable in accordance with their terms, except to the extent that enforcement thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws affecting the enforcement of creditors’ rights generally, and there exists no event or condition which will result in a material violation or breach
of or constitute (with or without due notice or lapse of time or both) a default by the Company or any of its Subsidiaries under any such License Agreement. 
 (c) The Company and its Subsidiaries own or have the valid right to use all of the Intellectual Property that is necessary for the conduct of the Company’s and each of its Subsidiaries’ respective businesses
as currently conducted or as currently proposed to be conducted and for the ownership, maintenance and operation of the Company’s and its Subsidiaries’ properties and assets, free and clear of all liens, encumbrances, adverse claims or
obligations to license all such owned Intellectual Property and Confidential Information, other than licenses entered into in the ordinary course of the Company’s and its Subsidiaries’ businesses. The Company and its Subsidiaries have a
valid and enforceable right to use all third party Intellectual Property and Confidential Information used or held for use in the respective businesses of the Company and its Subsidiaries. 
 3.14 Environmental Matters. Neither the Company nor any of the Subsidiaries has been notified in writing that it is liable with respect to
obligations under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, or any similar law, statute, rule, regulatory decision or order of any governmental agency or body or any court, domestic or foreign
relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), except for
any liability as would not have a Material Adverse Effect, and it is not aware of any facts or circumstances which could reasonably be expected to result in any such liability. The Company and the Subsidiaries are in substantial compliance with all
applicable existing Environmental Laws, except for such instances of non-compliance which would not have a Material Adverse Effect. The term “Hazardous Material” means (i) any “hazardous substance” as defined by the
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, (ii) any “hazardous waste” as defined by the Resource Conservation and Recovery Act, as amended, (iii) any petroleum or petroleum product,
(iv) any polychlorinated biphenyl and (v) any pollutant or 

  

 17 

 
contaminant or hazardous, dangerous or toxic chemical, material, waste or substance regulation under or within the meaning of any other Environmental Law. To
the Company’s Knowledge, no disposal, release or discharge of “Hazardous Material” has occurred on, in, at or about any of the facilities or properties of the Company or any of the Subsidiaries, except for any such disposal, release
or discharge which is in compliance with Environmental Laws or which would not have a Material Adverse Effect. Except as described in the SEC Filings, to the Company’s Knowledge: (A) there has been no storage, disposal, generation,
transportation, handling or treatment of hazardous substances or solid wastes by the Company or any of the Subsidiaries (or to the Company’s Knowledge, any of its predecessors in interest) at, upon or from any of the property now or previously
owned or leased by the Company or any of the Subsidiaries in violation of any applicable law, ordinance, rule, regulation, order, judgment, decree or permit or which would require remedial action which has not been taken, under any applicable law,
ordinance, rule, regulation, order, judgment, decree or permit, except for such violations and failures to take remedial action which would not result in, singularly or in the aggregate, a Material Adverse Effect; and (B) there has been no
material spill, discharge, leak, emission, injection, escape, dumping or release of any kind onto such property or into the environment surrounding such property by the Company or any of the Subsidiaries of any solid waste or Hazardous Materials,
except for such spills, discharges, leaks, emissions, injections, escapes, dumping or releases which would not result in, singularly or in the aggregate, a Material Adverse Effect. 
 3.15 Litigation. There is no action, suit, proceeding, litigation or governmental proceeding pending or, to the Company’s Knowledge,
threatened or contemplated against (or circumstances that are reasonably likely to give rise to the same), or involving the properties or businesses of, the Company or any of the Subsidiaries which questions the validity of any of the capital stock
of the Company (including, without limitation, the Shares) or any of the Subsidiaries, this Agreement or any of the other Transaction Documents, or of any action taken or to be taken by the Company or any of the Subsidiaries pursuant to or in
connection with this Agreement or any of the other Transaction Documents. Except as described on Schedule 3.15, there are no pending actions, suits or proceedings against or affecting the Company, its Subsidiaries or any of its or their
properties involving an amount in controversy in excess of $150,000; and to the Company’s Knowledge, no such actions, suits or proceedings are threatened or contemplated. 
 3.16 Financial Statements. The consolidated financial statements of the Company and the Subsidiaries together with the related notes thereto
included in the Annual Report on Form 10-K and the most recent Quarterly Report on Form 10-Q included among the SEC Filings fairly present in all material respects the financial position, income, changes in stockholders’ equity, cash flow and
results of operations of the Company and the Subsidiaries at the respective dates and for the respective periods to which they apply, and such financial statements have been prepared in conformity with United States generally accepted accounting
principles applied on a consistent basis (“GAAP”) throughout the periods involved (except as may be disclosed therein or in the notes thereto, and, in the case of quarterly financial statements, as permitted by Form 10-Q under the
Securities Act). Except as set forth in the financial statements of the Company set forth in the Annual Report on Form 10-K and the most recent Quarterly Report on Form 10-Q included among the SEC Filings, since the date of the latest financial
statements included in the most recent Quarterly Report on Form 10-Q included among 

  

 18 

 
the SEC Filings: (i) neither the Company nor any of its Subsidiaries has incurred any liabilities, contingent or otherwise, except those incurred in the
ordinary course of business, consistent (as to amount and nature) with past practices, none of which, individually or in the aggregate, have had or could reasonably be expected to have a Material Adverse Effect; (ii) there has been no material
adverse change or development involving a prospective material change in the condition, financial or otherwise, or in the earnings, business, prospects or results of operations of the Company and the Subsidiaries, taken as a whole, whether or not
arising in the ordinary course of business; (iii) neither the Company nor any Subsidiary has entered into any material transaction other than in the ordinary course of business; and (iv) the Company has not declared or paid any dividend or
made any other distribution on or in respect of its capital stock. The outstanding debt, the property, both tangible and intangible, and the businesses of each of the Company and the Subsidiaries conform in all material respects to the descriptions
thereof contained in the Annual Report on Form 10-K and the most recent Quarterly Report on Form 10-Q included among the SEC Filings. 
 3.17
Insurance Coverage. The Company and each Subsidiary maintains in full force and effect insurance coverage that is customary for comparably situated companies for the business being conducted and properties owned or leased by the Company and
each Subsidiary, and the Company reasonably believes such insurance coverage to be adequate against all liabilities, claims and risks against which it is customary for comparably situated companies to insure. 
 3.18 Compliance with Nasdaq Continued Listing Requirements. The Common Stock is registered pursuant to Section 12(g) of the Exchange Act, and
is approved for listing on the Nasdaq Capital Market under the symbol “VEXP”. The Company is in compliance with applicable Nasdaq continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge,
threatened against the Company relating to the continued listing of the Company’s Common Stock on the Nasdaq Capital Market and the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the
delisting of the Common Stock from the Nasdaq Capital Market. The Company has taken no action that was designed to terminate trading of the Common Stock on the Nasdaq Capital Market, nor has the Company received any notification that the Commission
or Nasdaq is contemplating terminating such trading. 
 3.19 No Directed Selling Efforts or General Solicitation. Neither the Company,
nor, to the Company’s Knowledge, any Affiliate of the Company, nor any Person acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) in connection
with the offer or sale of any of the Shares. 
 3.20 No Integrated Offering. Neither the Company nor, to the Company’s Knowledge,
any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances that would adversely affect reliance
by the Company on Section 4(2) and/or Regulation D for the exemption from registration for the transactions contemplated hereby or would require registration of the Shares under the Securities Act. 
  

 19 

 3.21 Private Placement. Assuming the truth and accuracy of Exeter Capital’s representations
set forth in Section 4 of this Agreement, the offer and sale of the Securities to Exeter Capital as contemplated hereby is exempt from the registration requirements of the Securities Act. 
 3.22 Questionable Payments. Neither the Company nor any of the Subsidiaries has, nor, to the Company’s Knowledge, has any
officer, director or employee of the Company or any of the Subsidiaries or any other person acting on behalf of the Company or any of the Subsidiaries, for the benefit of the Company or any such Subsidiaries at any time during the last five years,
(i) made any unlawful gift or contribution to any candidate for federal, state, local or foreign political office, or failed to disclose fully any such gift or contribution in violation of law, or (ii) made any payment to any federal,
state, local or foreign governmental officer or official, which would be reasonably likely to subject the Company or any of the Subsidiaries to any damage or penalty in any civil, criminal or governmental litigation or proceeding (domestic or
foreign). Each of the Company’s and the Subsidiaries’ internal accounting controls are sufficient to cause the Company and the Subsidiaries to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.

 3.23 Transactions with Affiliates. Except as disclosed in the SEC Filings and except for the Expense Reimbursement Agreement by and
between the Company and TH Lee Putnam Ventures, none of the officers, directors or 5% or greater stockholders of the Company, and to the Company’s Knowledge none of their respective Affiliates and, to the Company’s Knowledge, none of the
employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than as holders of stock options and/or warrants, and for services as employees, officers and directors), including any contract, agreement or
other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the Company’s Knowledge,
any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner. 
 3.24
Internal Controls. Except as described in the SEC filings, the Company is in material compliance with the provisions of the Sarbanes-Oxley Act of 2002 currently applicable to the Company. The Company and the Subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the SEC Filings, the Company has
established disclosure controls and procedures (as defined in Exchange Act Rules 13a-13 and 15d-13) for the Company and designed such disclosure controls and procedures to ensure that material information relating to the Company, including the
Subsidiaries, is made known to the certifying officers by others within those entities, particularly during the period in which the Company’s most recently filed period report under the Exchange Act, as the case may be, is being prepared. The
Company’s certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of the end of the period covered by 
  

 20 

 
the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed
periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. The Company maintains and will continue to
maintain a standard system of accounting established and administered in accordance with GAAP and the applicable requirements of the Exchange Act. 
 3.25 Stabilization. None of the Company, any of the Subsidiaries or, to the Company’s Knowledge, any Affiliate of the Company or any Subsidiary, has taken or will take, directly or indirectly, any action designed to or which has
constituted or which might be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares or otherwise. 
 3.26 Taxes. Each of the Company and the Subsidiaries has filed all income and franchise tax returns required to be filed (after giving effect to
all permissible extensions) through the date hereof by it in any jurisdiction, and has paid all taxes shown to be due on such returns or claimed to be due from such entities, other than those being contested in good faith, except where the failure
to so file or pay would not have a Material Adverse Effect. All tax liabilities, including those being contested by the Company or the Subsidiaries are adequately reserved for in the Company’s financial statements (in accordance with GAAP). No
tax deficiency has been asserted and no tax proceedings are pending or, to the Company’s Knowledge, are threatened against the Company or any of the Subsidiaries which, if adversely determined would have a Material Adverse Effect, and to the
Company’s Knowledge, no such deficiency or proceeding is contemplated. 
 3.27 No Transfer Tax. No transfer tax, stamp duty or
other similar tax is payable by or on behalf of Exeter Capital in connection with (i) the issuance by the Company of the Shares, (ii) the purchase by Exeter Capital of Shares from the Company or (iii) the consummation by the Company
of any of its obligations under this Agreement. 
 3.28 Not Investment Company. The Company is not an “investment company”
or a company controlled by an “investment company” or, to the Company’s Knowledge, an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company” as such terms
are defined in the Investment Company Act of 1940, as amended. 
 4. Representations, Warranties and Covenants of Exeter Capital.

 4.1 Exeter Capital Knowledge and Status. Exeter Capital represents and warrants to, and covenants with, the Company that:
(i) it is an “accredited investor” as defined in Regulation D under the Securities Act and has requested, received, reviewed and considered all information it deemed relevant in making an informed decision to purchase the Shares, and
has such business and financial experience as is required to give it the capacity to utilize the information received, to evaluate the risks involved in purchasing the Shares, and to protect its own interests in connection with the purchase of the
Shares and is able to bear the risks of an investment in the Shares; (ii) it understands that the Shares are “restricted securities” and have not been registered under the Securities Act and is acquiring the number of Shares set forth
on 
  

 21 

 
the Exhibit A hereto in the ordinary course of its business and for its own account for investment only, has no present intention of distributing any
of such Shares and has no arrangement or understanding with any other persons regarding the distribution of such Shares; (iii) it will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to
buy, purchase or otherwise acquire or take a pledge of) any of the Shares except in compliance with the Securities Act, applicable state securities laws and the respective rules and regulations promulgated thereunder; and (iv) it has, in
connection with its decision to purchase the number of Shares set forth on the signature page hereto, relied only upon the representations and warranties of the Company contained herein. Exeter Capital understands that the Shares to be issued to it
have not been registered under the Securities Act, or registered or qualified under any state securities law in reliance on specific exemptions therefrom, which exemptions may depend upon, among other things, the bona fide nature of its investment
intent as expressed herein, and it is able to bear the economic risk of holding the Shares for an indefinite period of time and can afford a complete loss of its investment. 
 4.2 International Actions. Exeter Capital acknowledges, represents and agrees that no action has been or will be taken in any jurisdiction outside
the United States by the Company that would permit an offering of the Shares, or possession or distribution of offering materials in connection with the issue of the Shares, in any jurisdiction outside the United States. 
 4.3 Registration Required. Exeter Capital hereby covenants with the Company not to make any sale of the Shares without complying with the
provisions of this Agreement and the Registration Rights Agreement, and without effectively causing the prospectus delivery requirement under the Securities Act to be satisfied (unless Exeter Capital is selling such Shares in a transaction not
subject to the prospectus delivery requirement), and it acknowledges that the certificates evidencing the Shares will be imprinted with a legend that prohibits their transfer except in accordance therewith. Exeter Capital acknowledges that as set
forth in, and subject to the provisions of, the Registration Rights Agreement, there may occasionally be times when the Company, based on the advice of its counsel, determines that it must suspend the use of the prospectus forming a part of the
Registration Statement until such time as an amendment to the Registration Statement has been filed by the Company and declared effective by the Commission or until the Company has amended or supplemented such prospectus. 
 4.4 Power and Authority. Exeter Capital further represents and warrants to, and covenants with, the Company that (i) it is duly organized and
in good standing in the jurisdiction of its organization, (ii) it has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize
the execution, delivery and performance of this Agreement, and (ii) this Agreement has been duly authorized, executed and delivered, and constitutes a valid and binding obligation of it enforceable against it in accordance with its terms,
except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general
principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 
  

 22 

 4.5 Prohibited Transactions. During the last thirty (30) days prior to the date hereof,
neither Exeter Capital nor any Affiliate of Exeter Capital, which (x) had knowledge of the transactions contemplated hereby, (y) has or shares discretion relating to Exeter Capital’s investments or trading or information concerning
Exeter Capital’s investments, including in respect of the Shares, or (z) is subject to Exeter Capital’s review or input concerning such Affiliate’s investments or trading (collectively, “Trading Affiliates”), has,
directly or indirectly, effected or agreed to effect any short sale, whether or not against the box, established any “put equivalent position” (as defined in Rule 16a-1(h) under the Exchange Act) with respect to the Common Stock, granted
any other right (including, without limitation, any put or call option) with respect to the Common Stock or with respect to any security that includes, relates to or derived any significant part of its value from the Common Stock or otherwise sought
to hedge its position in the Shares (each, a “Prohibited Transaction”). Prior to the earliest to occur of (i) the termination of this Agreement, (ii) the effective date for the registration of the Shares, or (iii) 180 days
after the Closing Date, Exeter Capital shall not, and shall cause its Trading Affiliates not to, engage, directly or indirectly, in a Prohibited Transaction. 
 4.6 No Tax or Legal Advice. Exeter Capital understands that nothing in this Agreement, or any other materials presented to Exeter Capital in connection with the purchase and sale of Shares hereunder constitutes
legal, tax or investment advice. Exeter Capital has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Shares. 
 5. Company Covenants. 
 5.1
Maintain Listing. The Company will use commercially reasonable efforts to maintain the listing of its common stock on the Nasdaq Capital Market or a recognized securities exchange registered with the Securities and Exchange Commission.

 5.2 Regulation D Notice. The Company agrees to file a Notice of Sale of Securities pursuant to Regulation D, Section 4(6),
and/or Uniform Limited Offering Exemption on Form D with respect to the Shares as required under Regulation D and to provide a copy thereof to Exeter Capital promptly after such filing. 
 5.3 Restriction on Integrated Offering. The Company shall not, and it shall use reasonable efforts to ensure that no Affiliate of the Company
will, “offer,” “sell” or solicit offers to buy or otherwise negotiate in respect of any “security” (as each of such terms are defined in the Securities Act) which could be integrated with the sale of the Shares in a
manner that would require the registration of the Shares under the Securities Act 
 6. Filing of Form 8-K. To the extent required by
law, no later than the fourth trading day following the Closing Date, the Company will file a Current Report on Form 8-K attaching copies of the Transaction Documents. In addition, the Company will make such other filings and notices in the manner
and time required by the Commission or Nasdaq. 
 7. Survival of Representations, Warranties and Agreements. All covenants,
agreements, representations and warranties made by the Company and Exeter Capital herein shall survive the execution of this Agreement, the delivery to Exeter Capital of the Shares being purchased and the payment therefore. 
  

 23 

 8. Notices. All notices, requests, consents and other communications hereunder shall be in
writing, shall be mailed (A) if within domestic United States by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or by facsimile or electronic mail, or (B) if delivered from
outside the United States, by International Federal Express (or comparable service) or facsimile or electronic mail, and shall be deemed given (i) if delivered by first-class registered or certified mail domestic, three business days after so
mailed, (ii) if delivered by nationally recognized overnight carrier, one (1) business day after so mailed, (iii) if delivered by International Federal Express (or comparable service), two (2) business days after so mailed,
(iv) if delivered by facsimile or electronic mail, upon electric confirmation of receipt and shall be delivered as addressed as follows: 
 (a)     if to the Company, to: 
 Velocity Express Corporation 
 One Morningside Drive North 
 Building B
– Suite 300 
 Westport, CT 06880 
 Attention: 
 Telephone:
(952)                          
 Telecopy: (952)                          
 With a copy to:    Briggs and Morgan, P.A. 
 2200 IDS Center 
 80 South Eighth Street

 Minneapolis, MN 55402 
 Attn:
Avron L. Gordon 
 Telephone: (612) 977-8400 
 Telecopy: (612) 977-8650 
 Email: agordon@briggs.com 
 Budd Larner, PC 
 150 John F. Kennedy
Parkway 
 Short Hills, NJ 07078 
 Attn: James F. Fitzsimmons Esq. 
 Telephone (973) 315-4800 
 Telecopy: (973) 379-7734 
 (b) if to
Exeter Capital, at its address on Exhibit A hereto, or at such other address or addresses as may have been furnished to the Company in writing. 
 9. Changes. This Agreement may not be modified or amended except pursuant to an instrument in writing signed by the Company and Exeter Capital. 
  

 24 

 10. Headings. The headings of the various sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed to be part of this Agreement. 
 11. Severability. In case any provision
contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby. 
 12. Governing Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York. Service of
process in connection with any suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents
to the jurisdiction of the courts of the State of New York in any such suit, action or proceeding and to the laying of venue exclusively in New York. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action
or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. 
 13. Amendment and Waiver. No provision of this Agreement may be waived or amended except in a written instrument signed by the Company and Exeter
Capital. 
 14. Counterparts and Facsimiles. This Agreement may be executed in two or more counterparts, each of which shall
constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties. This Agreement may
also be executed and delivered via facsimile, which shall be deemed an original. 
 15. Confidential Disclosure Agreement.
Notwithstanding any provision of this Agreement to the contrary, any confidential disclosure agreement previously executed by the Company and Exeter Capital in connection with the transactions contemplated by this Agreement shall remain in full
force and effect in accordance with its terms following the execution of this Agreement and the consummation of the transactions contemplated hereby. 
 16. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or
obligations hereunder without the prior written consent of Exeter Capital. Exeter Capital may assign any or all of its rights under this Agreement to any Person to whom Exeter Capital assigns and transfers the Shares, provided that such transferee
(i) makes the representations of Exeter Capital under this Agreement, and (ii) agrees in writing to be bound with respect to the transferred Shares, by the provisions hereof that apply to Exeter Capital. 
 [Signature on Following Page] 
  

 25 

 IN WITNESS WHEREOF, the undersigned have read and hereby agree to the Terms and Conditions for
Exchange of Shares: 
  

			
	 Velocity Express Corporation,
 a Delaware corporation

		
	 By:
	 	 /s/ Edward W. Stone

	 Print Name: Edward W. Stone

	 Print Title:   Chief Financial Officer

  

			
	Exeter Capital Partners IV, L.P.
		
	 By:
	 	 Exeter IV Advisors, L.P.,
 General Partner

		
	 By:
	 	 Exeter IV Advisors, Inc.,
 General Partner

  

			
	 By:
	 	 /s/ Kurt Bergquist

	 Print Name: Kurt Bergquist

	 Print Title:   Vice President

 [Signature Page for Terms and Conditions for Exchange of Shares] 
  

 26 

 Schedule 3.12 
 Labor Matters 
 The California EDD is conducting an investigation of the classification of the
Company’s independent contractors. 
  

 1 

 Schedule 3.13 
 Intellectual Property 
 The Company anticipates that it will initiate concurrent use proceedings in order to
clarify territorial rights with respect to two “Velocity” trademark registrations (Velocity and Velocity Express). See attached correspondence from Keith B. Willhelm to James C. Lindvall dated March 31, 2006 and
Settlement Agreement by and between Velocity Courier, Inc. and Velocity Express, Inc. dated November 30, 2000. 
  

 1 

 Schedule 3.15 
 Litigation 
 [To be completed] 
  

 2 

 EXHIBIT B 
 STOCK AND WARRANT POWER 
 FOR VALUE RECEIVED, the undersigned, does, effective as of July 3, 2006 hereby
sell, assign and transfer unto VELOCITY EXPRESS CORPORATION: (i) Sixty Five Thousand Six Hundred Seventeen (65,617) shares of Series A Preferred Stock of CD&L, Inc., a Delaware corporation; (ii) Three Hundred Twenty Eight Thousand
Eighty Four (328,084) shares of Common Stock of CD&L, Inc., a Delaware corporation; and (iii) a Warrant entitling the undersigned to purchase up to Eighty Four Thousand Three Hundred Seventy Five (84,375) shares of Common Stock of
CD&L, Inc., a Delaware corporation, represented by Stock Certificates No.          and No         and Warrant No.
        , respectively, and does hereby irrevocably constitute and appoint the Secretary of the said corporation as attorney to transfer said stock and warrant on the books of said corporation with full
power of substitution in the premises. 
 IN WITNESS WHEREOF, the undersigned has set his hand as of the 3rd day of July, 2006. 

 

									
	[Medallion Guarantee]	 		 	 Exeter Capital Partners IV, L.P., a Delaware
 limited partnership

					
		 		 		 	 By:
	 	 Exeter IV Advisors, L.P.,
 General
Partner

					
		 		 		 	 By:
	 	Exeter IV Advisors, Inc.,
General Partner
					
	 By:
	 	 /s/ Edmund Go
	 		 	 By:
	 	 /s/ Kurt Bergquist

		 		 		 	 Print Name: Kurt Bergquist

		 		 		 	 Print Title:   Vice President

 [Stock and Warrant Power for Exeter Capital Series A Purchase Agreement (Share Consideration)]

  

 3 

 EXHIBIT C 
 REGISTRATION RIGHTS AGREEMENT 
  

 4 

 EXHIBIT D 
 WAIVER 
  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]